Datasets:
ChatDOC
/
OCRFlux-pubtabnet-single

Dataset card Data Studio Files Community
image_name
stringlengths
68
68
type
stringclasses
2 values
gt_table
stringlengths
116
12.6k
3618bab4f885022dad1deb09022351566efef76b05f7ae2984940fe3e7db3d23.png
simple
<table><tr><td>Interactions</td><td>Patientsn = 624n (%)</td></tr><tr><td>Potential drug-drug interactions</td><td>492 (78.8)</td></tr><tr><td>Number of potential drug-drug interactions*</td><td></td></tr><tr><td> 1</td><td>154 (24.7)</td></tr><tr><td> 2</td><td>92 (14.7)</td></tr><tr><td> 3&#8211;4</td><td>154 (24.7)</td></tr><tr><td> &#8805; 5</td><td>92 (14.7)</td></tr><tr><td>Type D</td><td>24 (3.8)</td></tr><tr><td> ACE* inhibitors + potassium-sparing diuretics (or potassium supplementation)</td><td>11 (1.8)</td></tr><tr><td> NSAID*+ Methotrexate</td><td>5 (0.8)</td></tr><tr><td> NSAID* +anticoagulants (or glucocorticoids)</td><td>5 (0.8)</td></tr><tr><td> &#946; blocking agents + Verapamil (or Fluoxetin)</td><td>3 (0.4)</td></tr><tr><td>Type C</td><td>468 (75.0)</td></tr><tr><td> ACE* inhibitors + NSAID*</td><td>252 (40.4)</td></tr><tr><td> NSAID*+ low dose ASA*</td><td>212 (34.0)</td></tr><tr><td> NSAID*+ sulfonylureas</td><td>128 (20.5)</td></tr><tr><td> ACE* inhibitors + low dose ASA*</td><td>130 (20.8)</td></tr><tr><td> &#946; blocking agents + NSAID*</td><td>107 (17.1)</td></tr><tr><td> NSAID* + Diuretics</td><td>105 (16.8)</td></tr><tr><td> ACE* inhibitors + glybenclamide</td><td>68 (10.9)</td></tr><tr><td> NSAID*+ other NSAID*</td><td>51 (8.2)</td></tr><tr><td> ACE* inhibitors + thiazide diuretics</td><td>47 (7.6)</td></tr><tr><td> Pravastatin + bezafibrate</td><td>35 (5.6)</td></tr><tr><td> Pentoxiyilline + antihypertensives</td><td>37 (5.9)</td></tr><tr><td> Metformin+ ranitidine</td><td>40 (6.5)</td></tr><tr><td> Glibenclamide + antimycotics or cotrimoxazole</td><td>24 (3.9)</td></tr><tr><td> Furosemide + ACE* inhibitors</td><td>21 (3.4)</td></tr><tr><td> ACE* inhibitors + antiacids</td><td>19 (3.1)</td></tr><tr><td> Alendronate + NSAIDs*</td><td>18 (2.9)</td></tr><tr><td> Insulin + antihypertensive</td><td>18 (2.9)</td></tr><tr><td> Pentoxifylline + hypoglycemic agents</td><td>14 (2.2)</td></tr><tr><td> Acetaminophen + carbamazepin</td><td>14 (2.2)</td></tr><tr><td> Ranitidine + azole type of antimycotics</td><td>11 (1.8)</td></tr><tr><td> Others</td><td>61 (9.4)</td></tr><tr><td>Potential drug-disease interactions</td><td>400 (64.1)</td></tr><tr><td>Number of potential drug-disease interactions</td><td></td></tr><tr><td> 1</td><td>346 (55.4)</td></tr><tr><td> &#8805; 2</td><td>54 (8.7)</td></tr><tr><td>NSAIDs* in patients with hypertension and/or chronic heart failure</td><td>384 (61.5)</td></tr><tr><td>&#946; blocking agents in patients with diabetes mellitus</td><td>31 (5.0)</td></tr><tr><td>NSAIDs* in patients with chronic renal insufficiency</td><td>18 (2.9)</td></tr><tr><td>NSAIDs* in patients with previous peptic ulcer</td><td>8 (1.3)</td></tr><tr><td>Thiazides diuretics in patients with gout</td><td>7 (1.1)</td></tr><tr><td>Metformin in patients with chronic renal insufficiency or congestive heart failure</td><td>6 (1.0)</td></tr><tr><td>&#946; blocking agents in patients with peripheral vascular disease</td><td>4 (0.6)</td></tr><tr><td>&#946; blocking agents in patients with asthma/COPD*</td><td>3 (0.5)</td></tr><tr><td>Others</td><td>5 (1.0)</td></tr></table>
7e9658042b7f67f3ed6eba618c9db71a61b8e06bfc228833f6c5142a9e8849f6.png
simple
<table><tr><td>District</td><td>Number</td><td>Percent</td></tr><tr><td>Gulu</td><td></td><td></td></tr><tr><td>Total anaemia</td><td>117</td><td>32.9</td></tr><tr><td>Mild anaemia</td><td>82</td><td>23.0</td></tr><tr><td>Moderate anaemia</td><td>32</td><td>9.0</td></tr><tr><td>Severe anaemia</td><td>3</td><td>0.8</td></tr><tr><td>Hoima</td><td></td><td></td></tr><tr><td>Total anaemia</td><td>47</td><td>12.1</td></tr><tr><td>Mild anaemia</td><td>35</td><td>9.0</td></tr><tr><td>Moderate anaemia</td><td>10</td><td>2.5</td></tr><tr><td>Severe anaemia</td><td>2</td><td>0.5</td></tr></table>
271bda6c50432c5b6268376d6de46eae541349aa0bafa9e3272c4dd9c9df01b5.png
simple
<table><tr><td>Gene type</td><td>Number of genes*</td><td>Differentially expressed*</td><td>Enrichment <i>p</i>-value**</td><td>Enrichment status<sup>+</sup></td></tr><tr><td>Housekeeping</td><td>3292</td><td>29</td><td>1.60E-13</td><td>Depleted</td></tr><tr><td>Weak promoter</td><td>5262</td><td>118</td><td>0.07</td><td>Depleted</td></tr><tr><td>Narrow promoter</td><td>930</td><td>43</td><td>1.20E-04</td><td>Enriched</td></tr><tr><td>Broad promoter</td><td>1279</td><td>51</td><td>9.50E-04</td><td>Enriched</td></tr><tr><td>Bivalent</td><td>3400</td><td>166</td><td>4.90E-18</td><td>Enriched</td></tr></table>
14435865fd493b6db26d5233f79a1891e329029d9af443c3975cb806111dad51.png
complex
<table><tr><td rowspan="3"></td><td colspan="5">CT</td><td colspan="8">MRI</td><td>DSA</td></tr><tr><td colspan="3">unenhanced</td><td colspan="2">enhancement</td><td colspan="5">unenhanced</td><td colspan="3">Gd-DTPA-enhanced</td><td>enhancement</td></tr><tr><td>shape</td><td>border</td><td>density</td><td>Arterial phase</td><td>Venous phase</td><td>shape</td><td>border</td><td>T1WI</td><td>T2WI</td><td>DWI</td><td>Arterialphase</td><td>Venousphase</td><td>Delayphase</td><td></td></tr><tr><td>case1</td><td>M-R-O</td><td>well</td><td>hypo</td><td>hetero</td><td>moderate</td><td>Lob</td><td>well</td><td>hypo</td><td>hyper</td><td>sig. Hyper</td><td>hetero</td><td>hyper</td><td>moderate</td><td>hyper</td></tr><tr><td>case2</td><td>M-R-O</td><td>well</td><td>hypo</td><td>hetero</td><td>moderate</td><td>Lob</td><td>well</td><td>hypo</td><td>hyper</td><td>sig. Hyper</td><td>hetero</td><td>moderate</td><td>mild</td><td>hyper</td></tr><tr><td>case3</td><td>M-R</td><td>well</td><td>hypo</td><td>hetero</td><td>moderate</td><td>Lob</td><td>well</td><td>hypo</td><td>hyper</td><td>hyper</td><td>hetero</td><td>moderate</td><td>mild</td><td>hyper</td></tr><tr><td>case4</td><td>M-R-O</td><td>well</td><td>hypo</td><td>hetero</td><td>moderate</td><td>Lob</td><td>well</td><td>hypo</td><td>hyper</td><td>sig. Hyper</td><td>hetero</td><td>hyper</td><td>moderate</td><td>hyper</td></tr><tr><td>case5</td><td>M-R-O</td><td>well</td><td>hypo</td><td>hetero</td><td>moderate</td><td>Lob</td><td>well</td><td>hypo</td><td>hyper</td><td>sig. Hyper</td><td>hetero</td><td>hyper</td><td>moderate</td><td>hyper</td></tr><tr><td>case6</td><td>M-O</td><td>well</td><td>hypo</td><td>hetero</td><td>moderate</td><td>M-N</td><td>well</td><td>hypo</td><td>hyper</td><td>sig. Hyper</td><td>hetero</td><td>moderate</td><td>mild</td><td>hyper</td></tr><tr><td>case7</td><td>M-O</td><td>well</td><td>hetero, hypo</td><td>hetero</td><td>moderate</td><td>M-N</td><td>well</td><td>hypo</td><td>hyper</td><td>sig. Hyper</td><td>hetero</td><td>moderate</td><td>mild</td><td>hyper</td></tr><tr><td>case8</td><td>S-R</td><td>well</td><td>hypo</td><td>homo</td><td>mild</td><td>nodule</td><td>well</td><td>hypo</td><td>hyper</td><td>hyper</td><td>homo</td><td>moderate</td><td>mild</td><td>hyper</td></tr><tr><td>case9</td><td></td><td></td><td></td><td></td><td></td><td>M-N</td><td>well</td><td>hypo</td><td>hyper</td><td>sig. Hyper</td><td>hetero</td><td>moderate</td><td>mild</td><td>hyper</td></tr><tr><td>case10</td><td></td><td></td><td></td><td></td><td></td><td>M-N</td><td>well</td><td>hypo</td><td>hyper</td><td>sig. Hyper</td><td>hetero</td><td>mild</td><td>mild</td><td>hyper</td></tr><tr><td>case11</td><td></td><td></td><td></td><td></td><td></td><td>Irr</td><td>well</td><td>hetero</td><td>hyper</td><td>hyper</td><td>hetero</td><td>hetero</td><td>hetero</td><td>hetero</td></tr></table>
c07c8a1c68d941c14128851e330ca783d3e3f510b33b3e0d7be0acbdd860c098.png
complex
<table><tr><td> </td><td colspan="4">Outlet type</td></tr><tr><td>Anti-malarials</td><td colspan="2">Private</td><td colspan="2">Not-for-profit</td></tr><tr><td> </td><td>Median price (range) USD</td><td>Median price ratio</td><td>Median price (range) USD</td><td>Median price ratio</td></tr><tr><td>AL*</td><td>0.94 (0.63-1.25)</td><td>1.88</td><td>0.75 (0.63-1.00)</td><td>1.5</td></tr><tr><td>Other forms of ACT**</td><td>6.0 (1.88-10.63)</td><td>12</td><td>2.5 (1.88-3.13)</td><td>5</td></tr><tr><td>Quinine*</td><td>1.0 (0.75-1.25)</td><td>1.33</td><td>0.75 (0.63-1.13)</td><td>1</td></tr></table>
a622d4135181a0a59c6bdccf48eeb3ef4c5e27f971cb137f5eb1e5fb22f964eb.png
complex
<table><tr><td colspan="2">UUY (Phe)</td><td colspan="2">AAY (Asn)</td><td colspan="2">AAR (Lys)</td><td colspan="2">AGR (Arg)</td></tr><tr><td>Leu</td><td>0.00</td><td>Asn</td><td>-0.02</td><td>Lys</td><td>-0.27</td><td>Gly</td><td>0.00</td></tr><tr><td>Ile</td><td>0.32</td><td>Asp</td><td>0.00</td><td>Gln</td><td>-0.16</td><td>Ser</td><td>0.36</td></tr><tr><td>Phe</td><td>0.41</td><td>Glu</td><td>0.23</td><td>Glu</td><td>0.00</td><td>Ala</td><td>0.48</td></tr><tr><td>Met</td><td>0.73</td><td>Gln</td><td>0.53</td><td>Arg</td><td>0.24</td><td>Asn</td><td>0.68</td></tr><tr><td>Val</td><td>0.75</td><td>Lys</td><td>1.09</td><td>Asn</td><td>0.46</td><td>Thr</td><td>0.69</td></tr><tr><td>Tyr</td><td>2.17</td><td>His</td><td>1.11</td><td>His</td><td>1.04</td><td>Pro</td><td>0.77</td></tr><tr><td>Cys</td><td>2.21</td><td>Ser</td><td>1.20</td><td>Asp</td><td>1.13</td><td>Asp</td><td>0.80</td></tr><tr><td>Trp</td><td>2.37</td><td>Pro</td><td>1.21</td><td>Pro</td><td>1.89</td><td>Gln</td><td>0.86</td></tr><tr><td>Thr</td><td>2.83</td><td>Thr</td><td>1.27</td><td>Thr</td><td>2.10</td><td>Cys</td><td>0.86</td></tr><tr><td>His</td><td>3.38</td><td>Arg</td><td>1.55</td><td>Tyr</td><td>2.27</td><td>His</td><td>0.88</td></tr><tr><td>Pro</td><td>3.41</td><td>Ala</td><td>1.92</td><td>Ser</td><td>2.66</td><td>Glu</td><td>0.92</td></tr><tr><td>Ala</td><td>3.55</td><td>Tyr</td><td>2.11</td><td>Met</td><td>3.62</td><td>Met</td><td>1.11</td></tr><tr><td>Gln</td><td>4.18</td><td>Gly</td><td>2.20</td><td>Ala</td><td>3.84</td><td>Lys</td><td>1.14</td></tr><tr><td>Ser</td><td>4.39</td><td>Met</td><td>2.50</td><td>Trp</td><td>3.86</td><td>Val</td><td>1.22</td></tr><tr><td>Asn</td><td>4.76</td><td>Cys</td><td>2.79</td><td>Phe</td><td>4.48</td><td>Tyr</td><td>1.22</td></tr><tr><td>Arg</td><td>4.98</td><td>Leu</td><td>3.05</td><td>Leu</td><td>4.81</td><td>Arg</td><td>1.23</td></tr><tr><td>Glu</td><td>5.24</td><td>Phe</td><td>3.06</td><td>Gly</td><td>4.81</td><td>Leu</td><td>1.26</td></tr><tr><td>Lys</td><td>5.37</td><td>Val</td><td>3.06</td><td>Cys</td><td>4.99</td><td>Ile</td><td>1.32</td></tr><tr><td>Asp</td><td>5.77</td><td>Trp</td><td>3.06</td><td>Val</td><td>5.06</td><td>Phe</td><td>1.36</td></tr><tr><td>Gly</td><td>6.02</td><td>Ile</td><td>3.29</td><td>Ile</td><td>5.26</td><td>Trp</td><td>1.58</td></tr></table>
c69a19e4823b66bb8716759f1aa71f719a99f2d69c190b34a134457335dc1290.png
complex
<table><tr><td>Introduced Mutation</td><td>B19V Internalization (%) in the Presence of Competing VP1u <sup>1</sup></td><td>Remaining VP1u Function (%) <sup>2</sup></td></tr><tr><td colspan="3"><i>Truncations</i></td></tr><tr><td>WT</td><td>4.0</td><td>100</td></tr><tr><td>&#8710;N5</td><td>4.1</td><td>99.9</td></tr><tr><td>&#8710;N11</td><td>17.0</td><td>20.5</td></tr><tr><td>&#8710;N20</td><td>52.9</td><td>3.7</td></tr><tr><td>&#8710;N30</td><td>97.4</td><td>0.1</td></tr><tr><td>&#8710;C126</td><td>3.7</td><td>108.4</td></tr><tr><td>&#8710;C137</td><td>4.5</td><td>90.0</td></tr><tr><td>&#8710;C147</td><td>4.9</td><td>81.3</td></tr><tr><td>&#8710;C159</td><td>28.1</td><td>10.8</td></tr><tr><td>&#8710;C170</td><td>84.8</td><td>0.8</td></tr><tr><td colspan="3"><i>Mutations in helix 1</i></td></tr><tr><td>E14A</td><td>3.4</td><td>121.3</td></tr><tr><td>F15C</td><td>47.5</td><td>4.7</td></tr><tr><td>F15W</td><td>20.6</td><td>16.2</td></tr><tr><td>A16S</td><td>4.1</td><td>98.5</td></tr><tr><td>V19A</td><td>28.8</td><td>10.4</td></tr><tr><td>V19S</td><td>31.1</td><td>9.3</td></tr><tr><td>Y20C</td><td>26.3</td><td>11.8</td></tr><tr><td>Y20W</td><td>6.6</td><td>60.1</td></tr><tr><td>Q21A</td><td>14.4</td><td>25.1</td></tr><tr><td>Q21P</td><td>50.7</td><td>4.1</td></tr><tr><td>Q22A</td><td>66.2</td><td>2.2</td></tr><tr><td>Q22P</td><td>90.8</td><td>0.4</td></tr><tr><td>F23S</td><td>41.6</td><td>5.9</td></tr><tr><td>F26S</td><td>24.4</td><td>13.1</td></tr><tr><td>Y27C</td><td>71.4</td><td>1.7</td></tr><tr><td>Y27W</td><td>26.4</td><td>11.8</td></tr><tr><td>K29A</td><td>4.2</td><td>96.4</td></tr><tr><td colspan="3"><i>Double-glycine mutations</i></td></tr><tr><td>WW8/9GG</td><td>26.8</td><td>11.5</td></tr><tr><td>TD33/34GG</td><td>52.3</td><td>3.9</td></tr><tr><td>SL48/49GG</td><td>62.1</td><td>2.6</td></tr><tr><td>EN54/55GG</td><td>50.7</td><td>4.1</td></tr><tr><td>LF59/60GG</td><td>85.3</td><td>0.7</td></tr></table>
6a5f49c472dcbc131a848371a6b352d6c4c563b491ccc9cb07c82a15fae098d2.png
simple
<table><tr><td>VariableOral morphine equivalents, mg</td><td>Pre Group(<i>n</i> = 276)</td><td>ERAS Group(<i>n</i> = 96)</td><td><i>p</i>-value</td></tr><tr><td>Total Opioid use, <i>Mean (SD)</i></td><td>163.8 (73.2)</td><td>111.4 (46.0)</td><td>&lt; 0.001<sup>*</sup></td></tr><tr><td>Intraop Opioid use, <i>Mean (SD)</i></td><td>93.6 (33.8)</td><td>73.4 (29.8)</td><td>&lt; 0.001<sup>*</sup></td></tr><tr><td>PACU Opioid use, <i>Mean (SD)</i></td><td>36.7 (30.8)</td><td>15.4 (19.3)</td><td>&lt; 0.001<sup>*</sup></td></tr><tr><td>Hospital Floor Opioid use, <i>Mean (SD)</i></td><td>33.4 (44.5)</td><td>22.6 (19.3)</td><td>0.001<sup>*</sup></td></tr></table>
2b2aac4ecf308101c7967409dfeb989a212bf561ae1ef389e4355451e953170b.png
simple
<table><tr><td>Lichen species</td><td>Phenolics content&#956;g of pyrocatechol equivalent</td><td>Flavonoid content&#956;g of rutin equivalent</td></tr><tr><td><i>C. furcata</i></td><td>12.95 &#177; 1.065</td><td>10.55 &#177; 1.099</td></tr><tr><td><i>L. atra</i></td><td>73.02 &#177; 1.275</td><td>54.77 &#177; 1.231</td></tr><tr><td><i>L. muralis</i></td><td>43.19 &#177; 1.085</td><td>34.56 &#177; 1.074</td></tr></table>
0bae9017e1c9d063d2dcaa0bb2975b331928b47c275d2ef1c87a886b100f3236.png
complex
<table><tr><td>Disease</td><td></td><td colspan="5">Days after inoculation</td></tr><tr><td></td><td></td><td>8</td><td>11</td><td>14</td><td>17</td><td>20</td></tr><tr><td><i>Cercospora </i>leaf spot</td><td>Overall accuracy [%]</td><td>98.90</td><td>89.01</td><td>96.58</td><td>98.73</td><td></td></tr><tr><td></td><td>Kappa coefficient</td><td>0.99</td><td>0.53</td><td>0.92</td><td>0.98</td><td></td></tr><tr><td></td><td>Diseased leaf area [%]</td><td>0</td><td>6.56</td><td>7.61</td><td>20.92</td><td></td></tr><tr><td>Powdery mildew</td><td>Overall accuracy [%]</td><td>94.34</td><td>96.79</td><td>97.23</td><td>90.18</td><td></td></tr><tr><td></td><td>Kappa coefficient</td><td>0.88</td><td>0.91</td><td>0.95</td><td>0.84</td><td></td></tr><tr><td></td><td>Diseased leaf area [%]</td><td>14.40</td><td>19.37</td><td>41.94</td><td>50.04</td><td></td></tr><tr><td>Sugar beet rust</td><td>Overall accuracy [%]</td><td></td><td></td><td></td><td></td><td>61.70</td></tr><tr><td></td><td>Kappa coefficient</td><td></td><td></td><td></td><td></td><td>0.56</td></tr><tr><td></td><td>Diseased leaf area [%]</td><td></td><td></td><td></td><td></td><td>2.89</td></tr></table>
3e44eb9842acbf747a4732254c4fa1bb14b565c901a33ba53d570caa43151056.png
simple
<table><tr><td>Knowledge domain</td><td>Unadjusted OR (95 % CI)</td><td>Adjusted OR (95 % CI)</td></tr><tr><td>Overall knowledge</td><td>1.02 (0.64, 1.63)</td><td>1.07 (0.65, 1.75)</td></tr><tr><td> Child health</td><td>1.29 (0.50, 1.24)</td><td>1.19 (0.73, 1.96)</td></tr><tr><td> Postpartum</td><td>1.24 (0.78, 1.95)</td><td>1.22 (0.75, 1.99)</td></tr><tr><td> Newborn care</td><td>1.24 (0.78, 1.95)</td><td>1.16 (0.70, 1.90)</td></tr><tr><td> Injury prevention</td><td>1.24 (0.77, 1.98)</td><td>1.19 (0.71, 1.98)</td></tr><tr><td> Nutrition</td><td>1.05 (0.67, 1.66)</td><td>1.05 (0.65, 1.74)</td></tr><tr><td> Family planning</td><td>0.97 (0.61, 1.52)</td><td>0.99 (0.61, 1.60)</td></tr><tr><td> HIV</td><td>0.85 (0.54, 1.34)</td><td>0.88 (0.54, 1.44)</td></tr><tr><td> Pregnancy</td><td>0.79 (0.50, 1.24)</td><td>0.77 (0.47, 1.27)</td></tr><tr><td> Infection prevention</td><td>0.79 (0.50, 1.25)</td><td>0.75 (0.47, 1.20)</td></tr><tr><td> Malaria</td><td>0.68 (0.43, 1.09)</td><td>0.69 (0.42, 1.15)</td></tr></table>
cef9ba2e6a78768f1a070825953055af99e6235f383a63e8e0aa90106e510f7b.png
simple
<table><tr><td>S. No.</td><td>Name of the seed</td><td>Hot water extraction (%)</td><td>Pressurized hot water extraction (%)</td><td>Solvent extraction (%)</td></tr><tr><td>1.</td><td><i>Syzygium cumini</i></td><td>16.07</td><td>49.24</td><td>78.14</td></tr><tr><td>2.</td><td><i>Citrus sinensis</i></td><td>19.80</td><td>74.79</td><td>75.65</td></tr><tr><td>3.</td><td><i>Mangifera indica</i></td><td>59.54</td><td>84.76</td><td>65.17</td></tr><tr><td>4.</td><td><i>Vitis vinifera</i></td><td>68.87</td><td>79.86</td><td>83.31</td></tr><tr><td>5.</td><td><i>Manilakara zapota</i></td><td>44.72</td><td>81.59</td><td>81.24</td></tr><tr><td>6.</td><td><i>Artocarpus heterophyllus</i></td><td>40.92</td><td>87.52</td><td>82.68</td></tr></table>
5623d8c19d723a363ea9deb5cbfdabe83ac35e63c8ea3955f9299cbed2c11a64.png
complex
<table><tr><td></td><td></td><td colspan="3">Male</td></tr><tr><td></td><td></td><td>Heinz 1706</td><td>LA716</td><td>Periclinal 1</td></tr><tr><td rowspan="3">Female</td><td>Heinz 1706</td><td>Yes</td><td>Yes</td><td>Yes</td></tr><tr><td>LA716</td><td>No</td><td>Yes</td><td>No</td></tr><tr><td>Periclinal 1</td><td>No</td><td>Yes</td><td>No</td></tr></table>
2e631b70d42a6d5ead0443c6adddff0923779cb40eee21b4e192bce1362f9757.png
complex
<table><tr><td rowspan="2"></td><td>U2OS-Cas9</td><td>U2OS-Cas9</td><td>U2OS-Cas9</td><td>HeLa-Cas9</td><td>HeLa-Cas9</td><td>HeLa-Cas9</td></tr><tr><td>No gRNA</td><td>EMX1-RNA</td><td>EMX1-BNA-5</td><td>No gRNA</td><td>EMX1-RNA</td><td>EMX1-BNA-5</td></tr><tr><td>EMX1</td><td>0.004</td><td>69.181</td><td>27.393</td><td>&lt;0.003</td><td>69.118</td><td>25.649</td></tr><tr><td>EMX1-OT1</td><td>0.005</td><td>12.233</td><td>&lt;0.003</td><td>0.009</td><td>11.677</td><td>&lt;0.003</td></tr><tr><td>EMX1-OT2</td><td>0.031</td><td>1.007</td><td>0.020</td><td>0.025</td><td>0.607</td><td>0.020</td></tr><tr><td>EMX1-OT3</td><td>0.068</td><td>&lt;0.003</td><td>0.047</td><td>0.005</td><td>&lt;0.003</td><td>&lt;0.003</td></tr><tr><td>EMX1-OT4</td><td>0.073</td><td>&lt;0.003</td><td>&lt;0.003</td><td>0.042</td><td>0.016</td><td>0.051</td></tr><tr><td>EMX1-OT5</td><td>&lt;0.003</td><td>0.113</td><td>0.002</td><td>0.060</td><td>0.141</td><td>&lt;0.003</td></tr></table>
2556816abf71b22ee11ce8f14f7c39ad492d4cb3f8c1362df7daac22b661478c.png
complex
<table><tr><td>Province</td><td>District</td><td>Village</td><td>No. of larvae</td></tr><tr><td rowspan="3">Nangarhar</td><td>Behsood</td><td>Banaghar, Samarkhel, Saracha</td><td>200</td></tr><tr><td>Jalalabad</td><td>Bagrami</td><td>200</td></tr><tr><td>Kama</td><td>Banajur, Sabirlalay, Sangarsary</td><td>200</td></tr><tr><td rowspan="3">Kunar</td><td>Chawkay</td><td>Babur</td><td>200</td></tr><tr><td>Nurgal</td><td>Nurgal</td><td>200</td></tr><tr><td>Assadabad</td><td>Asadabad</td><td>200</td></tr></table>
b0bf83e88f4d4a2bcdd0d8b5175ef76b60b5071403fb3d1db62afcfadca2d15a.png
simple
<table><tr><td>PCR target</td><td>Midguts from mosquitoes fed on gametocyte cultureMean Cp (95% CI)</td><td>Midguts with microscopy-confirmed <i>P. falciparum</i> oocystsMean Cp (95% CI)</td></tr><tr><td>EHV</td><td>24.75(24.68&#8211;24.82)</td><td>24.14(23.68&#8211;24.61)</td></tr><tr><td>RPS7</td><td>22.85(22.68&#8211;23.02)</td><td>23.03(22.0&#8211;24.07)</td></tr></table>
b34bcf5def7262cc04bd99fed2c3b1f2c89c68937508b8a2fbf998a82f63c350.png
simple
<table><tr><td>Characteristics</td><td>IRS (<i>n</i>=798) No (%)</td><td>Replastered (<i>n</i>=59) No (%)</td><td>Owns at least one LLIN (<i>n</i>=1,879) No (%)</td><td>Uses at least one LLIN (<i>n</i>=630) No (%)</td><td>Chi-square test (<i>P</i> value)</td></tr><tr><td>Heard about malaria (<i>n</i>=2,867)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes</td><td>670 (84.0)</td><td>56 (94.9)</td><td>1,559 (83.0)</td><td>534 (84.8)</td><td>3.12 (0.08)</td></tr><tr><td>No</td><td>128 (16.0)</td><td>3 (5.1)</td><td>320 (17.0)</td><td>96 (15.2)</td><td></td></tr><tr><td>Malaria is a communicable disease (<i>n</i>=2,463)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes</td><td>464 (58.1)</td><td>35 (59.3)</td><td>1,064 (56.6)</td><td>416 (66.0)</td><td>35.20 (0.0001)</td></tr><tr><td>No</td><td>191 (23.9)</td><td>18 (30.5)</td><td>448 (23.8)</td><td>107 (16.9)</td><td></td></tr><tr><td>I do not know</td><td>11 (14)</td><td>3 (5.1)</td><td>39 (2.1)</td><td>9 (1.4)</td><td></td></tr><tr><td>Route of transmission of malaria (<i>n</i>=1,413)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Mosquito bite</td><td>365 (46.0)</td><td>26 (44.1)</td><td>668 (35.6)</td><td>339 (53.8)</td><td>99.80 (0.0001)</td></tr><tr><td>Others</td><td>97 (12.2)</td><td>9 (15.3)</td><td>400 (21.3)</td><td>79 (12.5)</td><td></td></tr><tr><td>Malaria is a preventable disease (<i>n</i>=2,463)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes</td><td>591 (74.1)</td><td>47 (79.7)</td><td>1,296 (69.0)</td><td>490 (77.8)</td><td>45.18 (0.0001)</td></tr><tr><td>No</td><td>73 (9.1)</td><td>8 (13.6)</td><td>193 (10.3)</td><td>39 (6.2)</td><td></td></tr><tr><td>I don't know</td><td>7 (0.9)</td><td>1 (1.7)</td><td>73 (3.9)</td><td>6 (1.0)</td><td></td></tr><tr><td>Malaria is a severe disease (<i>n</i>=2,463)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes</td><td>665 (83.3)</td><td>55 (93.2)</td><td>1,540 (82.0)</td><td>527 (83.7)</td><td>Not valid</td></tr><tr><td>No</td><td>4 (0.5)</td><td>0 (0.0)</td><td>11 (0.6)</td><td>5 (0.8)</td><td></td></tr><tr><td>I don't know</td><td>1 (0.1)</td><td>1 (1.7)</td><td>2 (0.1)</td><td>2 (0.3)</td><td></td></tr><tr><td>Malaria is a curable disease (<i>n</i>=2,463)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Yes</td><td>669 (83.4)</td><td>56 (94.9)</td><td>1,472 (78.3)</td><td>526 (83.5)</td><td>Not valid</td></tr><tr><td>No</td><td>2 (0.3)</td><td>0 (0.0)</td><td>79 (4.2)</td><td>5 (0.8)</td><td></td></tr><tr><td>I don't know</td><td>0 (0.0)</td><td>0 (0.0)</td><td>1 (0.02)</td><td>1 (0.2)</td><td></td></tr></table>
c3c8058025e731a81d623e8ab51a3a8b981042a4409a97718e873bbdbb9ce8f3.png
complex
<table><tr><td rowspan="2"></td><td rowspan="2">Proton concordant &amp; HiSeq discordant</td><td rowspan="2">HiSeq concordant &amp; Proton discordant</td><td rowspan="2">All concordant</td><td colspan="3">Both discordant</td></tr><tr><td>Total</td><td>HiSeq = Proton</td><td>All discordant</td></tr><tr><td>Average</td><td>64</td><td>1849</td><td>76945</td><td>216</td><td>202</td><td>14</td></tr><tr><td>%CV</td><td>19.6</td><td>55.6</td><td>1.24</td><td>4.23</td><td>5.51</td><td>31.6</td></tr><tr><td>Common</td><td>1</td><td>43</td><td>66472</td><td>80</td><td>67</td><td>1</td></tr></table>
d15bf0cbfdc8eef1cd472778aa2e86f7c23c4fcd453b0577440b5da800dd66fe.png
simple
<table><tr><td>Label claim Mg/tablet</td><td>Amount added %</td><td>Total amount added (mg)</td><td>Amount recovered* (mg) &#177; SD</td><td>% Recovery &#177; SD (<i>n</i> = 3)</td></tr><tr><td>Risperidone</td><td>50</td><td>1</td><td>0.99 &#177; 0.02</td><td>99.66 &#177; 1.79</td></tr><tr><td>2</td><td>100</td><td>2</td><td>2.01 &#177; 0.02</td><td>100.21 &#177; 1.11</td></tr><tr><td></td><td>150</td><td>3</td><td>3.01 &#177; 0.04</td><td>100.31 &#177; 1.46</td></tr></table>
2664cc2060a309f8ba4eb0213e38e17c80876ddc3650fa29e3e1899070d4c86d.png
complex
<table><tr><td colspan="2"><i>EcoR</i>I primers</td><td colspan="2"><i>Mse</i>I primers</td></tr><tr><td>Name</td><td>Sequence</td><td>Name</td><td>Sequence</td></tr><tr><td>E1</td><td>AAC</td><td>M1</td><td>CAA</td></tr><tr><td>E2</td><td>AAG</td><td>M2</td><td>CAC</td></tr><tr><td>E3</td><td>ACA</td><td>M3</td><td>CAG</td></tr><tr><td>E4</td><td>ACT</td><td>M4</td><td>CAT</td></tr><tr><td>E5</td><td>ACC</td><td>M5</td><td>CTA</td></tr><tr><td>E6</td><td>ACG</td><td>M6</td><td>CTC</td></tr><tr><td>E7</td><td>AGC</td><td>M7</td><td>CTG</td></tr><tr><td>E8</td><td>AGG</td><td>M8</td><td>CTT</td></tr></table>
6093c43b8bdaf4be6cf198c3b5bb8417a41548a70a79ca95d8f33eb22112f5c9.png
simple
<table><tr><td></td><td>Control</td><td>Group F0.5</td><td>Group F1.0</td></tr><tr><td>Gender (M/F)</td><td>17/13</td><td>14/16</td><td>15/15</td></tr><tr><td>Age (yrs)</td><td>78.2 &#177; 9.2</td><td>79.6 &#177; 6.1</td><td>82.1 &#177; 7.9</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td><td>23.3 &#177; 2.2</td><td>25.2 &#177; 1.5</td><td>24.5 &#177; 2.5</td></tr><tr><td>ASA (II/III)</td><td>24/6</td><td>25/5</td><td>27/3</td></tr><tr><td>Hypertension</td><td>26/4</td><td>24/6</td><td>26/4</td></tr><tr><td>Diabetes</td><td>17/13</td><td>18/12</td><td>15/15</td></tr><tr><td>Drug allergies</td><td>3/27</td><td>3/27</td><td>4/26</td></tr><tr><td>Smoking history</td><td>11/19</td><td>12/18</td><td>11/19</td></tr><tr><td>Snoring</td><td>10/20</td><td>9/21</td><td>8/22</td></tr><tr><td>Colonoscopy time (min)</td><td>15.2 &#177; 1.8</td><td>14.6 &#177; 2.2</td><td>16.2 &#177; 1.9</td></tr></table>
f274a1f5355b957f2ab3b8058bdb2b7d183be1fffe1a15d1e762d9258ef0fc6b.png
complex
<table><tr><td></td><td colspan="4">All diarrhea cases</td><td colspan="3">Severe cases</td></tr><tr><td></td><td>n</td><td>%*</td><td>95% CI</td><td>deff</td><td>n</td><td>%*</td><td>95% CI</td></tr><tr><td>Total (N = 2940)</td><td>1066</td><td>36.8</td><td>[33.7-40.0]</td><td>3.2</td><td>98</td><td>3.4</td><td>[2.2-4.6]</td></tr><tr><td>By district</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Aguie (N = 735)</td><td>250</td><td>34.0</td><td>[28.2-39.8]</td><td>2.9</td><td>15</td><td>1.5</td><td>[0.6-2.5]</td></tr><tr><td> Guidan Roumdji (N = 735)</td><td>273</td><td>40.1</td><td>[33.1-47.1]</td><td>5.2</td><td>28</td><td>5.3</td><td>[2.2-8.5]</td></tr><tr><td> Maradi CU (N = 735)</td><td>219</td><td>32.0</td><td>[27.4-36.7]</td><td>2.0</td><td>14</td><td>1.8</td><td>[0.7-2.9]</td></tr><tr><td> Madarounfa (N = 735)</td><td>324</td><td>44.2</td><td>[38.7-49.6]</td><td>1.2</td><td>41</td><td>5.5</td><td>[3.2-7.8]</td></tr><tr><td>By age (months)</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> 0-2 (N = 100)</td><td>19</td><td>16.6</td><td>[8.1-25.0]</td><td>1.3</td><td>1</td><td>1.5</td><td>[0.0-4.4]</td></tr><tr><td> 3-5 (N = 160)</td><td>49</td><td>35.0</td><td>[22.8-47.1]</td><td>3.0</td><td>4</td><td>3.8</td><td>[0.0-9.1]</td></tr><tr><td> 6-11 (N = 382)</td><td>202</td><td>54.2</td><td>[48.0-60.5]</td><td>1.7</td><td>17</td><td>4.0</td><td>[0.2-6.1]</td></tr><tr><td> 12-17 (N = 206)</td><td>203</td><td>52.1</td><td>[45.8-58.3]</td><td>1.7</td><td>18</td><td>4.0</td><td>[0.9-7.0]</td></tr><tr><td> 18-23 (N = 153)</td><td>150</td><td>37.3</td><td>[30.3-44.3]</td><td>2.0</td><td>9</td><td>1.3</td><td>[0.3-2.3]</td></tr><tr><td> 24-59 (N = 1492)</td><td>443</td><td>28.8</td><td>[25.2-32.3]</td><td>2.3</td><td>49</td><td>3.7</td><td>[2.2-5.1]</td></tr></table>
0bca652a5361f1a4f4c2a4deab47cf69122270d485df683538f676838f0143a2.png
simple
<table><tr><td>Property</td><td>PRD File</td><td>FAM File</td></tr><tr><td>Identifier</td><td>PRD_######, e.g., PRD_000001</td><td>FAM_######, e.g., FAM_000001</td></tr><tr><td>Name</td><td>Molecule name</td><td>Family name</td></tr><tr><td>Description</td><td>&#8226; Molecular formula and weight</td><td>&#8226; List of member PRD identifiers</td></tr><tr><td></td><td>&#8226; Specific function (class)</td><td>&#8226; Literature references</td></tr><tr><td></td><td>&#8226; Structural details (type)</td><td></td></tr><tr><td>Chemical details</td><td>&#8226; List of polymer and nonpolymer entities comprising the molecule</td><td>&#8226; Synonyms for PRD family members collected from various resources including the PDB and primary citations</td></tr><tr><td></td><td>&#8226; Polymer or subcomponent sequence&#8226; Description of how all components in the molecule are linked</td><td>&#8226; Reference database IDs and links to various resources that provide information about the family members</td></tr><tr><td></td><td> &#9675; Intra-entity linkages between components in polymer entities</td><td>&#8226; Family specific annotations</td></tr><tr><td></td><td> &#9675; Inter-entity linkages between polymer segments and nonpolymer components (for molecules with grouped representation)</td><td> &#9675; IDs and information about related small molecule crystal structures in the CSD16</td></tr><tr><td></td><td></td><td> &#9675; Corresponding literature references</td></tr><tr><td>Biological details</td><td>Name of organism producing the molecule (for naturally produced molecules) and source of this information (e.g. from a database, author or literature)</td><td>Annotations about structural, functional and mechanistic details for family members, including pharmacological action (where appropriate)</td></tr></table>
3ce022442574d2d0861a2c99c9e4cb1202f109e4c661d87d39175a314eb93446.png
simple
<table><tr><td>Time of measurement</td><td>Before therapy</td><td>After therapy (RCI)</td><td>Follow-up (RCI)</td></tr><tr><td>Outcome variable</td><td></td><td></td><td></td></tr><tr><td>PG-13</td><td>42</td><td>31 (2.66)</td><td>23 (4.59)</td></tr><tr><td>CAPS&#8212;total</td><td>50</td><td>27 (3.61)</td><td>13 (5.81)</td></tr><tr><td>CAPS&#8212;Intrusion</td><td>17</td><td>7 (2.66)</td><td>5 (3.19)</td></tr><tr><td>CAPS&#8212;Avoidance</td><td>25</td><td>14 (2.27)</td><td>6 (3.92)</td></tr><tr><td>CAPS&#8212;Hyper arousal</td><td>10</td><td>6 (1.23 NS)</td><td>2 (2.47)</td></tr><tr><td>BDI</td><td>22</td><td>15 (2.09)</td><td>11 (3.28)</td></tr></table>
68330f37bed2f41f283c502d5c6ee0df4c33bb6f8e57a5b43faf560ce583f8bb.png
simple
<table><tr><td> </td><td>MAP</td><td>Anti-MAP IgG</td></tr><tr><td>T1DM</td><td>3/10 (30%)</td><td>5/10 (50%)</td></tr><tr><td>T2DM</td><td>1/2 (50%)</td><td>1/2 (50%)</td></tr><tr><td>CONTROL</td><td>3/6 (50%)</td><td>2/6 (33.33%)</td></tr></table>
5898204a370e9ab2a92b63894d29312e84fe347e3e8b08854e3c6e8ef135ed7d.png
complex
<table><tr><td rowspan="3">Premises</td><td rowspan="2" colspan="3">Area (Wales)</td><td colspan="6">Location and Violence Strata</td></tr><tr><td colspan="2">Urban</td><td colspan="2">Town/Fringe</td><td colspan="2">Rural</td></tr><tr><td>North</td><td>West</td><td>South East</td><td>High</td><td>Low</td><td>High</td><td>Low</td><td>High</td><td>Low</td></tr><tr><td>Total (<i>N</i> = 30)</td><td>4</td><td>2</td><td>24</td><td>8</td><td>6</td><td>3</td><td>10</td><td>1</td><td>2</td></tr><tr><td>Intervention (<i>N</i> = 16)</td><td>2</td><td>1</td><td>13</td><td>5</td><td>3</td><td>1</td><td>6</td><td>0</td><td>1</td></tr><tr><td>Control (<i>N</i> = 14)</td><td>2</td><td>1</td><td>11</td><td>3</td><td>3</td><td>2</td><td>4</td><td>1</td><td>1</td></tr></table>
55e8c476190ce080cfe33c876da8b59fccfc0b6a1410facb259e3d14588acd8f.png
simple
<table><tr><td>Health problem</td><td>Overall</td><td>Boy</td><td>Girl Significance</td></tr><tr><td>Myopia</td><td>27.1</td><td>25.8</td><td>28.5***</td></tr><tr><td>Caries</td><td>69.6</td><td>70.0</td><td>69.1***</td></tr><tr><td>Obesity</td><td>9.5</td><td>10.6</td><td>8.4***</td></tr><tr><td>Dysarthria</td><td>2.5</td><td>3.0</td><td>2.0***</td></tr><tr><td>Cryptorchidism</td><td>-</td><td>2.1</td><td>-</td></tr><tr><td>Heart murmur</td><td>1.5</td><td>1.6</td><td>1.5</td></tr><tr><td>Scoliosis</td><td>0.4</td><td>0.4</td><td>0.4</td></tr><tr><td>Atopic dermatitis</td><td>0.2</td><td>0.2</td><td>0.2</td></tr></table>
794f67b3974cc8d339571bc5d9c8358c3762c6a6b9c01aeed60ec5f2e592a068.png
simple
<table><tr><td>Dysregulated miRNA (Reference)</td><td>Expression status</td><td>Proposed target gene</td></tr><tr><td> miR-1 [53] let-7d [55] miR-17 and miR-20a [57] miR-29 [58-59] miR-34 [63] miR-99 family (miR-100 and miR-99a) [64] miR-125b [41] miR-126 [66] miR-133a [67] miR-138 [70-71] miR-153 [72] miR-200 [73] miR-200c [74] miR-222 [75] miR-363 [77] miR-375 [1] </td><td> Underexpression Underexpression Underexpression Underexpression Overexpression Underexpression Underexpression Underexpression Underexpression Underexpression Underexpression Underexpression Underexpression Underexpression Underexpression Underexpression </td><td> TAGLN2Twist, Snail ITG&#946;8 LAMC2, ITGA6, TGF-&#946; Unknown IGFIR, mTOR KLF13, CXCL1 and FOXA1 VEGF-A, bFGF MSN GNA12, RhoC and ROCK2 SNAI1 and ZEB2 ZEB1,ZEB2 BMI1/ZEB1 MMP-1 Podoplanin(PDPN) Unknown </td></tr></table>
0435fef198aa83a0911a0b4a7eeff36b357dad5c35ed3f7edeafadcdf4458622.png
simple
<table><tr><td></td><td>Total</td><td>FUG</td><td>CUG</td><td>MFUG</td><td>MUG</td><td>NUG</td></tr><tr><td>Range (cm)</td><td>0.8&#8211;12.9</td><td>0.9&#8211;7.2</td><td>2.5&#8211;12.9</td><td>2.2&#8211;6.9</td><td>1.3&#8211;6.0</td><td>0.8&#8211;6.4</td></tr><tr><td>Mean &#177; SD</td><td>4.43 &#177; 2.37</td><td>3.38 &#177; 1.45</td><td>6.66 &#177; 2.66</td><td>4.45 &#177; 1.46</td><td>3.65 &#177; 1.68</td><td>3.67 &#177; 1.85</td></tr></table>
9c77f721efe7b22e729e013d7688296a21b24103c34d1f1dcd2b48a15c4c85b5.png
simple
<table><tr><td>Internet Resource</td><td>URL</td></tr><tr><td>Sequence motif searches</td><td></td></tr><tr><td>Pfam</td><td>http://www.sanger.co.uk/Pfam/</td></tr><tr><td>PRINTS</td><td>http://www.biochem.ucl.ac.uk/bsm/dbbrowser/PRINTS/</td></tr><tr><td>Prosite</td><td>http://www.expasy.org/prosite/</td></tr><tr><td>SMART</td><td>http://smart.embl-heidelberg.de</td></tr><tr><td>Superfamily</td><td>http://supfam.mrc-lmb.cam.ac.uk/SUPERFAMILY/hmm.html</td></tr><tr><td>Structural comparison</td><td></td></tr><tr><td>CATH</td><td>http://www.cathdb.info/latest/index.html</td></tr><tr><td>DaliLite</td><td>http://www.ebi.ac.uk/DaliLite/</td></tr><tr><td>SCOP</td><td>http://scop.mrc-lmb.cam.ac.uk/scop/</td></tr><tr><td>SSM</td><td>http://www.ebi.ac.uk/msd-srv/ssm/</td></tr><tr><td>Alignment software</td><td></td></tr><tr><td>BLAST</td><td>http://www.ncbi.nlm.nih.gov/blast/Blast.cgi</td></tr><tr><td>ClustalW</td><td>http://www.ebi.ac.uk/Tools/clustalw2/</td></tr><tr><td>Dcode</td><td>http://www.dcode.org</td></tr><tr><td>MEGA</td><td>http://www.megasoftware.net/</td></tr><tr><td>Muscle</td><td>http://www.ebi.ac.uk/muscle/</td></tr><tr><td>T-coffee</td><td>http://www.tcoffee.org/</td></tr><tr><td>Alignment optimization</td><td></td></tr><tr><td>GBlocks</td><td>http://molevol.ibmb.csic.es/Gblocks.html</td></tr><tr><td>GeneDoc</td><td>http://www.nrbsc.org/gfx/genedoc/index.html</td></tr><tr><td>PHYLIP</td><td>http://evolution.genetics.washington.edu/phylip.html</td></tr><tr><td>Phylogenetic analysis software</td><td></td></tr><tr><td>MrBayes</td><td>http://mrbayes.csit.fsu.edu/</td></tr><tr><td>PhyML</td><td>http://atgc.lirmm.fr/phyml/</td></tr><tr><td>PHYLIP</td><td>http://evolution.genetics.washington.edu/phylip.html</td></tr><tr><td>Tree-Puzzle</td><td>http://www.tree-puzzle.de/</td></tr><tr><td>MEGA</td><td>http://www.megasoftware.net/</td></tr><tr><td>Visualization</td><td></td></tr><tr><td>Pymol (structural)</td><td>http://pymol.sourceforge.net/</td></tr><tr><td>NJplot (phylogeny)</td><td>http://pbil.univ-lyon1.fr/software/njplot.html</td></tr><tr><td>MEGA</td><td>http://www.megasoftware.net/</td></tr><tr><td>Swiss-Model (structural)</td><td>http://swissmodel.expasy.org/</td></tr><tr><td>TreeView (phylogeny)</td><td>http://taxonomy.zoology.gla.ac.uk/rod/treeview.html</td></tr><tr><td>Databases</td><td></td></tr><tr><td>Ensembl (Sanger project)</td><td>http://www.ensembl.org</td></tr><tr><td>PDB</td><td>http://www.rcsb.org/pdb/home/home.do</td></tr><tr><td>NCBI</td><td>http://www.ncbi.nlm.nih.gov/sites/gquery?itool=toolbar</td></tr><tr><td>Superfamily</td><td>http://supfam.mrc-lmb.cam.ac.uk/SUPERFAMILY/hmm.html</td></tr><tr><td>UniProt</td><td>http://www.expasy.uniprot.org/</td></tr></table>
1b3a591047f7f14f21a72c07a37e5f8aa39e83eb014c09e1acf7db1e19cfa74f.png
simple
<table><tr><td>Parameter</td><td>Pediatric Journals(n = 42)</td><td>General Journals(n = 68)</td></tr><tr><td>Risk of Bias<sup>&#8224;</sup></td><td></td><td></td></tr><tr><td> Adequate Sequence Generation</td><td>29 (69)</td><td>53 (78)</td></tr><tr><td> Adequate Concealment of Allocation</td><td>23 (55)</td><td>50 (74)</td></tr><tr><td> Adequate Blinding of Participants and Providers</td><td>21 (50)</td><td>34 (50)</td></tr><tr><td> Adequate Blinding of Outcome Assessment</td><td>25 (60)</td><td>53 (78)</td></tr><tr><td> Adequate Handling of Missing Data</td><td>30 (72)</td><td>53 (78)</td></tr></table>
ad1a58fa15e4c0b6be1f905c17059501a42457becc969c31c16ed9f629ef75e2.png
complex
<table><tr><td> </td><td colspan="2">Stable plaque (SP) </td><td colspan="2">Unstable plaque (UP) </td><td rowspan="2"><i>P</i> value</td></tr><tr><td> </td><td>Median </td><td>25&#8211;75% CI</td><td>Median </td><td>25&#8211;75% CI</td></tr><tr><td>Fibrous cap (in <i>&#956;</i>m)</td><td>267</td><td>181&#8211;440</td><td>96</td><td>0&#8211;223</td><td><i>0.02 </i></td></tr><tr><td>LCR</td><td>0.21</td><td>0.08&#8211;0.28</td><td>0.64</td><td>0.54&#8211;0.76</td><td><i>&lt;0.001 </i></td></tr><tr><td>Neovessels (/0.2 mm<sup>2</sup>)</td><td>0</td><td>0&#8211;0.3</td><td>3</td><td>3&#8211;5</td><td><i>&lt;0.001 </i></td></tr></table>
a2eaa891f51634d0e6c906d8d0fc0a60c4bb86ab99250674a45b36785817f521.png
complex
<table><tr><td><i>Antipsychotics</i></td><td><i>MAOIs</i></td><td colspan="2"><i>Anticonvulsants/Anxiolytics/Others</i></td></tr><tr><td>Chlorpromazine</td><td>Hydroxylamine</td><td>Benztropine</td><td>Phenylephrine</td></tr><tr><td>Haloperidol</td><td>Selegiline</td><td>Phenytoin</td><td>Phenobarbital</td></tr><tr><td>Sulpiride</td><td>Pargyline</td><td>Diazepam</td><td>Chlordiazepoxide</td></tr><tr><td>Flupenthixol</td><td>Quinacrine</td><td>Nitrazepam</td><td></td></tr></table>
04f29ca664b8690bb04d90c1b1c3d0809f32f3446429482e3913a54d96073da4.png
simple
<table><tr><td></td><td>I.D. 34</td><td>I.D. 56</td><td>I.D. 81</td></tr><tr><td>Tube voltage [kV]</td><td>220</td><td>220</td><td>160</td></tr><tr><td>Tube current [&#956;A]</td><td>180</td><td>180</td><td>160</td></tr><tr><td>Power [W]</td><td>39.6</td><td>39.6</td><td>25.6</td></tr><tr><td>Exposure time [ms]</td><td>499</td><td>499</td><td>999</td></tr><tr><td>Filter</td><td>Cu 1 mm</td><td>Cu 1 mm</td><td>none</td></tr><tr><td>Number of projections</td><td>1200</td><td>1200</td><td>1200</td></tr><tr><td>Voxel size [&#956;m]</td><td>28</td><td>34</td><td>49.5</td></tr><tr><td>FOV in horizontal plane [mm]</td><td>33</td><td>58</td><td>82</td></tr><tr><td>FOV vertical [mm]</td><td>74</td><td>104</td><td>75</td></tr><tr><td>Measurement time [min]</td><td>40</td><td>60</td><td>20*</td></tr></table>
2fe4570781c59313ed7d74ccfbe403c4a57331db13c9fcb4146a321f0d6e9428.png
complex
<table><tr><td>MFI (mean &#177; SD)</td><td colspan="2">pDC</td><td></td><td colspan="2">mDC</td><td></td></tr><tr><td></td><td>Pre</td><td>Post</td><td><i>p</i></td><td>Pre</td><td>Post</td><td><i>p</i></td></tr><tr><td>HLA-DR</td><td>1673.5 &#177; 525.4</td><td>1523.4 &#177; 531.1</td><td><i>0.0092</i></td><td>2867.8 &#177; 440.9</td><td>2661.0 &#177; 573.2</td><td>0.1507</td></tr><tr><td>CD83</td><td>548.5 &#177; 187.7</td><td>755.0 &#177; 683.6</td><td>0.3982</td><td>374.9 &#177; 108.1</td><td>620.7 &#177; 392.5</td><td>0.0865</td></tr><tr><td>CD86</td><td>714.7 &#177; 174.0</td><td>743.6 &#177; 139.0</td><td>0.6359</td><td>1462.2 &#177; 322.8</td><td>1303.2 &#177; 328.0</td><td>0.4298</td></tr><tr><td>ICOSL</td><td>554.1 &#177; 223.8</td><td>640.4 &#177; 209.8</td><td>0.5265</td><td>498.2 &#177; 257.8</td><td>501.2 &#177; 133.7</td><td>0.9219</td></tr><tr><td>PD-L1</td><td>316.1 &#177; 110.7</td><td>376.8 &#177; 111.7</td><td>0.1848</td><td>272.0 &#177; 68.9</td><td>326.1 &#177; 88.6</td><td>0.1311</td></tr><tr><td>HLA-G</td><td>356.7 &#177; 57.8</td><td>409.9 &#177; 62.3</td><td>0.0583</td><td>567.7 &#177; 120.5</td><td>587.5 &#177; 108.4</td><td>0.6944</td></tr><tr><td>IL-T4</td><td>2303.6 &#177; 632.8</td><td>2743.4 &#177; 718.6</td><td><i>0.0165</i></td><td>1797.7 &#177; 424.0</td><td>2294.4 &#177; 570.7</td><td>0.0669</td></tr><tr><td>CD39</td><td>349.7 &#177; 116.9</td><td>437.8 &#177; 143.6</td><td><i>0.0456</i></td><td>1516.8 &#177; 269.2</td><td>1761.7 &#177; 527.6</td><td>0.2601</td></tr><tr><td>PD-L1/CD86</td><td>0.447 &#177; 0.110</td><td>0.5217 &#177; 0.197</td><td>0.3830</td><td>0.189 &#177; 0.042</td><td>0.268 &#177; 0.116</td><td>0.0929</td></tr></table>
edb4267251fe0d80c2ef937bbffff8e417c7cdb51bf0712acaa8475d5e80199b.png
complex
<table><tr><td> </td><td colspan="2"><underline>Outcome: high activity/behavior in children for corresponding activity/behavior category</underline></td></tr><tr><td>Maternal exposure</td><td>Baseline</td><td>Follow-up</td></tr><tr><td>Commuting</td><td> </td><td> </td></tr><tr><td> Low activity</td><td>1.00</td><td>1.00</td></tr><tr><td> High activity</td><td>2.72 (1.08, 6.87)<sup>&#8225;</sup></td><td>3.13 (1.37, 7.16)<sup>&#8224;</sup></td></tr><tr><td>Leisure-time sports</td><td> </td><td> </td></tr><tr><td> Low activity</td><td>1.00</td><td>1.00</td></tr><tr><td> High activity</td><td>3.61 (1.14, 11.41)<sup>&#8225;</sup></td><td>0.87 (0.26, 2.93)</td></tr><tr><td>Sedentary</td><td> </td><td> </td></tr><tr><td> Low sedentarybehavior</td><td>*</td><td>1.00</td></tr><tr><td> High sedentarybehavior</td><td>*</td><td>0.58 (0.35, 0.97)<sup>&#8225;</sup></td></tr></table>
fa7a2a42b62fc56ab64e753015b9e2ec0613e082b3f14e8e0a353e9f71b06eca.png
simple
<table><tr><td>Error size</td><td>Mean</td><td>SD</td><td>95% CI</td></tr><tr><td>Hit</td><td>6.86</td><td>3.86</td><td>[5.05, 8.67]</td></tr><tr><td>Small error</td><td>6.80</td><td>4.36</td><td>[4.76, 8.85]</td></tr><tr><td>Medium error</td><td>7.61</td><td>4.65</td><td>[5.43, 9.78]</td></tr><tr><td>Large error</td><td>10.48</td><td>4.68</td><td>[8.28, 12.67]</td></tr></table>
ac855a450658e68bc256566b44d5b1360515532d7931c826d6712cc0b506b2d2.png
complex
<table><tr><td rowspan="2"></td><td>No med (n = 82)</td><td>Metf (n = 132)</td><td>SU (n = 38)</td><td>Combi (n = 94)</td><td>All (n = 346)</td></tr><tr><td>Mean (SD)</td><td>Mean (SD)</td><td>Mean (SD)</td><td>Mean (SD)</td><td>Mean (SD)</td></tr><tr><td>Age (years)</td><td>60.7 (5.1)</td><td>59.6 (5.2)</td><td>60.6 (6.0)</td><td>60.0 (5.2)</td><td>60.1 (5.3)</td></tr><tr><td>SBP (mmHg)</td><td>169.7 (20.7)</td><td>162.7 (20.2)</td><td>162.5 (27.6)</td><td>162.4 (26.3)</td><td>164.3 (23.1)</td></tr><tr><td>DBP (mmHg)</td><td>86.9 (7.3)</td><td>89.9 (9.9)</td><td>93.1 (11.1)</td><td>88.0 (11.9)</td><td>89.3 (10.7)</td></tr><tr><td>Cholesterol (mmol/l)*</td><td>5.6 (1.0)</td><td>5.6 (1.0)</td><td>5.8 (1.3)</td><td>5.7 (1.1)</td><td>5.6 (1.1)</td></tr><tr><td>LDL (mmol/l)</td><td>3.5 (0.9)</td><td>3.7 (0.9)</td><td>3.9 (1.2)</td><td>3.8 (0.9)</td><td>3.7 (1.0)</td></tr><tr><td>HbA<sub>1c</sub> (%)*</td><td>6.3 (0.8)</td><td>7.3 (1.4)</td><td>7.0 (1.1)</td><td>8.2 (1.8)</td><td>7.3 (1.5)</td></tr><tr><td>BMI (kg/m<sup>2</sup>)*</td><td>29.2 (4.3)</td><td>31.9 (4.7)</td><td>29.7 (4.3)</td><td>30.3 (4.4)</td><td>30.6 (4.6)</td></tr><tr><td>Weight (kg)*</td><td>85.9 (15.7)</td><td>93.8 (15.6)</td><td>86.1 (16.7)</td><td>88.2 (15.1)</td><td>89.5 (15.9)</td></tr><tr><td>Waist circumference*</td><td>104.2 (12.2)</td><td>110.0 (11.4)</td><td>104.6 (14.6)</td><td>106.6 (11.7)</td><td>107.1 (12.2)</td></tr><tr><td>Statin use (n, (%))</td><td>7 (8.8)</td><td>17 (13.2)</td><td>5 (14.3)</td><td>14 (15.1)</td><td>43 (13.1)</td></tr></table>
292f01fe14ce497f05a212a3f248e93ed9e9c983ae9c2ab3bfd059e5a3e7ee39.png
simple
<table><tr><td>True stenosis [%]</td><td>Heart rate [bpm]</td><td>Method</td><td>Plaque diameter [mm]</td><td>Vessel diameter [mm]</td><td>Stenosis [%]</td><td>Deviation [PP]</td></tr><tr><td>12.5%</td><td>50</td><td>High pitch</td><td>1.13 &#177; 0.19</td><td>4.17 &#177; 0.35</td><td>27.0 &#177; 3.5</td><td>14.5</td></tr><tr><td> </td><td> </td><td>Gating</td><td>1.03 &#177; 0.19</td><td>4.23 &#177; 0.45</td><td>24.4 &#177; 3.7</td><td>11.9</td></tr><tr><td> </td><td>70</td><td>High pitch</td><td>1.12 &#177; 0.18</td><td>4.14 &#177; 0.35</td><td>27.1 &#177; 3.4</td><td>14.6</td></tr><tr><td> </td><td> </td><td>Gating</td><td>1.03 &#177; 0.19</td><td>4.26 &#177; 0.41</td><td>24.1 &#177; 3.6</td><td>11.6</td></tr><tr><td> </td><td>90</td><td>High pitch</td><td>1.11 &#177; 0.19</td><td>4.15 &#177; 0.30</td><td>26.7 &#177; 3.5</td><td>14.2</td></tr><tr><td> </td><td> </td><td>Gating</td><td>1.03 &#177; 0.19</td><td>4.22 &#177; 0.40</td><td>24.4 &#177; 3.4</td><td>11.9</td></tr><tr><td>25%</td><td>50</td><td>High pitch</td><td>1.63 &#177; 0.34</td><td>4.35 &#177; 0.38</td><td>37.2 &#177; 5.7</td><td>12.2</td></tr><tr><td> </td><td> </td><td>Gating</td><td>1.53 &#177; 0.33</td><td>4.35 &#177; 0.49</td><td>35.0 &#177; 4.6</td><td>10.0</td></tr><tr><td> </td><td>70</td><td>High pitch</td><td>1.65 &#177; 0.33</td><td>4.33 &#177; 0.36</td><td>37.8 &#177; 5.1</td><td>12.8</td></tr><tr><td> </td><td> </td><td>Gating</td><td>1.53 &#177; 0.34</td><td>4.35 &#177; 0.51</td><td>34.8 &#177; 4.6</td><td>9.8</td></tr><tr><td> </td><td>90</td><td>High pitch</td><td>1.66 &#177; 0.35</td><td>4.29 &#177; 0.39</td><td>38.4 &#177; 5.8</td><td>13.4</td></tr><tr><td> </td><td> </td><td>Gating</td><td>1.61 &#177; 0.36</td><td>4.36 &#177; 0.51</td><td>36.7 &#177; 5.2</td><td>11.7</td></tr><tr><td>50%</td><td>50</td><td>High pitch</td><td>2.19 &#177; 0.37</td><td>4.06 &#177; 0.20</td><td>53.9 &#177; 8.0</td><td>3.9</td></tr><tr><td> </td><td> </td><td>Gating</td><td>2.08 &#177; 0.28</td><td>3.95 &#177; 0.18</td><td>52.7 &#177; 6.2</td><td>2.7</td></tr><tr><td> </td><td>70</td><td>High pitch</td><td>2.16 &#177; 0.36</td><td>4.00 &#177; 0.23</td><td>54.0 &#177; 7.9</td><td>4.0</td></tr><tr><td> </td><td> </td><td>Gating</td><td>2.11 &#177; 0.27</td><td>3.99 &#177; 0.14</td><td>52.9 &#177; 6.1</td><td>2.9</td></tr><tr><td> </td><td>90</td><td>High pitch</td><td>2.20 &#177; 0.38</td><td>4.05 &#177; 0.21</td><td>54.4 &#177; 8.4</td><td>4.4</td></tr><tr><td> </td><td> </td><td>Gating</td><td>2.11 &#177; 0.32</td><td>3.96 &#177; 0.19</td><td>53.1 &#177; 6.7</td><td>3.1</td></tr></table>
d77169c8fdb8fb172902a724fbe9f05308119e89f753acc57a9eff0517559c2f.png
complex
<table><tr><td></td><td colspan="2">IFT-A</td><td colspan="6">IFT-B</td></tr><tr><td></td><td>IFT122</td><td>IFT140</td><td>IFT172</td><td>IFT52</td><td>IFT80</td><td>IFT88</td><td>TTC-26</td><td>TTC30a</td></tr><tr><td><i>Attheya septentrionalis</i></td><td></td><td></td><td></td><td>+</td><td></td><td></td><td></td><td></td></tr><tr><td><i>Aulacoseira subarctica</i></td><td>+</td><td></td><td></td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td><i>Chaetoceros curvisetus</i></td><td></td><td></td><td></td><td>+</td><td></td><td>+</td><td>+</td><td></td></tr><tr><td><i>Corethron hystrix</i></td><td></td><td></td><td></td><td>+</td><td></td><td></td><td></td><td></td></tr><tr><td><i>Corethron pennatum</i></td><td></td><td></td><td></td><td>+</td><td></td><td>+</td><td></td><td></td></tr><tr><td><i>Coscinodiscus wailesii</i></td><td></td><td></td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td><i>Cyclotella meneghiniana</i></td><td></td><td></td><td></td><td>+</td><td></td><td>+</td><td>+</td><td>+</td></tr><tr><td><i>Dactyliosolen fragilissimus</i></td><td></td><td></td><td></td><td>+</td><td>+</td><td></td><td></td><td></td></tr><tr><td><i>Ditylum brightwellii</i></td><td>+</td><td></td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td><i>Extubocellulus spinifer</i></td><td></td><td></td><td>+</td><td>+</td><td></td><td>+</td><td></td><td>+</td></tr><tr><td><i>Leptocylindrus aporus</i></td><td></td><td></td><td></td><td>+</td><td>+</td><td></td><td>+</td><td></td></tr><tr><td><i>Leptocylindrus danicus</i></td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td><i>Leptocylindrus hargravesii</i></td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td></td></tr><tr><td><i>Minutocellus polymorphus</i></td><td></td><td></td><td></td><td>+</td><td>+</td><td>+</td><td></td><td>+</td></tr><tr><td><i>Odontella aurita</i></td><td>+</td><td></td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td><i>Proboscia alata</i></td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td><i>Proboscia inermis</i></td><td></td><td></td><td></td><td></td><td>+</td><td>+</td><td>+</td><td></td></tr><tr><td><i>Rhizosolenia setigera</i></td><td>+</td><td>+</td><td>+</td><td>+</td><td></td><td>+</td><td></td><td></td></tr><tr><td><i>Skeletonema marinoi</i></td><td></td><td></td><td></td><td>+</td><td></td><td>+</td><td></td><td>+</td></tr><tr><td><i>Skeletonema menzelii</i></td><td></td><td></td><td></td><td>+</td><td></td><td></td><td></td><td>+</td></tr><tr><td><i>Stephanopyxis turris</i></td><td>+</td><td></td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td><i>Thalassiosira pseudonana</i><sup><i>a</i></sup></td><td></td><td></td><td></td><td>+</td><td></td><td>+</td><td></td><td>+</td></tr><tr><td><i>Thalassiosira rotula</i></td><td></td><td></td><td></td><td>+</td><td></td><td>+</td><td></td><td>+</td></tr><tr><td><i>Thalassiosira weissflogii</i></td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr></table>
46890f2b333b0bc0d33a3ca831e5583d34f62e84b47ed653c4ac7f0347444687.png
complex
<table><tr><td rowspan="3">Cell type</td><td rowspan="3">Environment</td><td rowspan="3">Number of animals</td><td>Peripheral</td><td>Intermediate</td><td>Central</td></tr><tr><td>% EdU + <sup>a</sup></td><td>% EdU + <sup>a</sup></td><td>% EdU + <sup>a</sup></td></tr><tr><td>Number of cells</td><td>Number of cells</td><td>Number of cells</td></tr><tr><td rowspan="2"><i>Vsx2</i><sup><i>orJ</i></sup></td><td rowspan="2"><i>orJ</i></td><td rowspan="2">4</td><td>4% &#177; 2%</td><td>20% &#177; 3%</td><td>31% &#177; 2%</td></tr><tr><td>1,880 cells</td><td>2,554 cells</td><td>2,490 cells</td></tr><tr><td><i>Vsx2</i><sup><i>orJ</i></sup></td><td>Mutant chimera</td><td>5</td><td>26% &#177; 8%</td><td>21% &#177; 4%</td><td>21% &#177; 5%</td></tr><tr><td></td><td></td><td></td><td>732 cells</td><td>798 cells</td><td>519 cells</td></tr><tr><td rowspan="2"><i>Vsx2</i><sup><i>wt</i></sup></td><td rowspan="2">Wild type</td><td rowspan="2">3</td><td>40% &#177; 5%</td><td>47% &#177; 4%</td><td>32% &#177; 3%</td></tr><tr><td>1,390 cells</td><td>2,207 cells</td><td>2,186 cells</td></tr><tr><td rowspan="2"><i>Vsx2</i><sup><i>wt</i></sup></td><td rowspan="2">Control chimera</td><td rowspan="2">4</td><td>46% &#177; 5%</td><td>42% &#177; 5%</td><td>28% &#177; 1%</td></tr><tr><td>594 cells</td><td>1,093 cells</td><td>883 cells</td></tr><tr><td rowspan="2"><i>Yfp</i><sup><i>+</i></sup></td><td rowspan="2">Mutant chimera</td><td rowspan="2">3</td><td>43% &#177; 8%</td><td>43% &#177; 8%</td><td>32% &#177; 5%</td></tr><tr><td>1,209 cells</td><td>2,608 cells</td><td>2,169 cells</td></tr><tr><td rowspan="2"><i>Yfp</i><sup><i>+</i></sup></td><td rowspan="2">Control chimera</td><td rowspan="2">4</td><td>47% &#177; 2%</td><td>44% &#177; 3%</td><td>38% &#177; 1%</td></tr><tr><td>809 cells</td><td>1,048 cells</td><td>1,378 cells</td></tr></table>
2dae2d1f77f5b1a5514e4e8b8391e29c20ecb8ca5b0666188897d47cd645b671.png
complex
<table><tr><td rowspan="2"></td><td colspan="4">Seropositivity S1</td><td colspan="4">Seropositivity S6</td></tr><tr><td>Proportion (%)</td><td>aOR</td><td>95% CI</td><td>p value</td><td>Proportion (%)</td><td>aOR</td><td>95% CI</td><td>p value</td></tr><tr><td colspan="4">Village</td><td rowspan="4"><i>0.0336</i></td><td></td><td></td><td></td><td rowspan="4">0.7022</td></tr><tr><td> Xe Xua</td><td>56.9</td><td>1.00</td><td></td><td>51.6</td><td>1.00</td><td></td></tr><tr><td> Tu Nak</td><td>40.4</td><td>432.80</td><td>[0.5&#8211;403,860]</td><td>56.9</td><td>1.12</td><td>[0.6&#8211;2.2]</td></tr><tr><td> Tak Lang</td><td>44.4</td><td>0.02</td><td>[0.001&#8211;0.6]</td><td>31.3</td><td>0.70</td><td>[0.2&#8211;2.1]</td></tr><tr><td colspan="4">Age group (years)</td><td rowspan="4"><i>&lt; 0.0001</i></td><td></td><td></td><td></td><td rowspan="4"><i>0.0001</i></td></tr><tr><td> 0.5&#8211;10</td><td>18.8</td><td>1.00</td><td></td><td>26.7</td><td>1.00</td><td></td></tr><tr><td> 11&#8211;25</td><td>47.1</td><td>1.99</td><td>[0.8&#8211;5]</td><td>46.7</td><td>1.31</td><td>[0.5&#8211;3.3]</td></tr><tr><td> &gt; 25</td><td>87.9</td><td>17.38</td><td>[5&#8211;58]</td><td>92.6</td><td>16.96</td><td>[4.0&#8211;71.2]</td></tr><tr><td colspan="4">Occupation</td><td rowspan="4"><i>0.0009</i></td><td></td><td></td><td></td><td rowspan="4">0.1167</td></tr><tr><td> School</td><td>33.9</td><td>1.00</td><td></td><td>33.0</td><td>1.00</td><td></td></tr><tr><td> Farmer</td><td>78.2</td><td>1.83</td><td>[0.7&#8211;5]</td><td>86.0</td><td>2.01</td><td>[0.6&#8211;6.6]</td></tr><tr><td> Other</td><td>7.7</td><td>0.13</td><td>[0.04&#8211;0.4]</td><td>24.3</td><td>0.54</td><td>[0.2&#8211;1.2]</td></tr><tr><td colspan="4">Main material of roof</td><td rowspan="3">0.738</td><td></td><td rowspan="3">NS</td><td></td><td></td></tr><tr><td> Leaves</td><td>36.4</td><td>1.00</td><td></td><td></td><td></td><td></td></tr><tr><td> Aluminium (tole)</td><td>50.3</td><td>1.09</td><td>[0.7&#8211;2]</td><td></td><td></td><td></td></tr><tr><td> Education</td><td></td><td>0.95</td><td>[0.8&#8211;1.1]</td><td>0.477</td><td></td><td>NS</td><td></td><td></td></tr><tr><td> Household</td><td></td><td>1.04</td><td>[1.0&#8211;1.1]</td><td><i>0.045</i></td><td></td><td>NS</td><td></td><td></td></tr><tr><td colspan="2">House structure</td><td rowspan="3">NS</td><td></td><td></td><td></td><td></td><td></td><td rowspan="3"><i>0.01</i></td></tr><tr><td> On ground</td><td></td><td></td><td></td><td>82.4</td><td>1.00</td><td></td></tr><tr><td> On stilts</td><td></td><td></td><td></td><td>48.1</td><td>0.24</td><td>[0.1&#8211;0.7]</td></tr><tr><td> Nr of buffaloes owned</td><td></td><td>NS</td><td></td><td></td><td></td><td>0.63</td><td>[0.4&#8211;0.9]</td><td><i>0.021</i></td></tr><tr><td> Total number of bednets in the household</td><td></td><td>NS</td><td></td><td></td><td></td><td>0.72</td><td>[0.5&#8211;1.0]</td><td>0.051</td></tr><tr><td> Total number of nights spent in the field</td><td></td><td>NA</td><td></td><td></td><td></td><td>1.00</td><td>[1.0&#8211;1.0]</td><td>0.854</td></tr><tr><td> Working in the forest during the study</td><td></td><td>NA</td><td></td><td></td><td></td><td>0.55</td><td>[0.2&#8211;1.5]</td><td>0.255</td></tr><tr><td> Total number of nights spent in the forest</td><td></td><td>NA</td><td></td><td></td><td></td><td>1.93</td><td>[0.6&#8211;6.5]</td><td>0.286</td></tr><tr><td> Having slept in another cluster during the study</td><td></td><td>NA</td><td></td><td></td><td></td><td>0.98</td><td>[0.3&#8211;3.1]</td><td>0.973</td></tr></table>
56a9db92c49e64d3823e7407906d8491ba93f2b609faf6d03b3aa4ad7d935546.png
complex
<table><tr><td>Patient</td><td> </td><td>Mild (n e %)</td><td>Moderate (n e %)</td><td>Severe (n e %)</td><td> p-value</td></tr><tr><td rowspan="5">Diagnosis</td><td>AD</td><td>28 (30.1%)</td><td>31 (33.3%)</td><td>8 (8.6%)</td><td>&lt;0.001*</td></tr><tr><td>VD</td><td>3 (3.2%)</td><td>0 (0%)</td><td>0 (0%)</td><td> </td></tr><tr><td>FTD</td><td>3 (3.2%)</td><td>2 (2.2%)</td><td>4 (4.3%)</td><td> </td></tr><tr><td>LBD</td><td>0 (0%)</td><td>1 (1.1%)</td><td>0 (0%)</td><td> </td></tr><tr><td>OD</td><td>6 (6.5%)</td><td>4 (4.3%)</td><td>3 (3.2%)</td><td> </td></tr><tr><td>Evolution (months)</td><td>Mean (&#177;SD)</td><td>53 (&#177;40)</td><td>58 (&#177;41)</td><td>99 (&#177;39)</td><td>&lt;0.001**,<sup>a</sup></td></tr><tr><td rowspan="6">Comorbidities</td><td>DM</td><td>12 (12.9%)</td><td>9 (9.7%)</td><td>2 (2.2%)</td><td>NS</td></tr><tr><td>Hypertension</td><td>24 (25.8%)</td><td>25 (26.9%)</td><td>3 (3.2%)</td><td>0.011**,<sup>a</sup></td></tr><tr><td>VbD</td><td>7 (7.5%)</td><td>6 (6.4%)</td><td>4 (4.3%)</td><td>NS</td></tr><tr><td>CvD</td><td>12 (12.9%)</td><td>18 (19.3%)</td><td>4 (4.3%)</td><td>NS</td></tr><tr><td>Other</td><td>21 (22.6%)</td><td>13 (14%)</td><td>5 (5.4%)</td><td>NS</td></tr><tr><td>Total by stage Mean (&#177;SD)</td><td>1.8 (&#177;1.2)</td><td>1.8 (&#177;1.2)</td><td>1.1 (&#177;1.3)</td><td>NS</td></tr><tr><td rowspan="3">Caregiver</td><td>Disease after taking on carer role</td><td>14 (15%)</td><td>15 (16%)</td><td>9 (10%)</td><td> </td></tr><tr><td>How long after (in months) Mean (&#177;SD)</td><td>29 (&#177;24)</td><td>30 (&#177;24)</td><td>35 (&#177;15)</td><td> </td></tr><tr><td>Use of medication prescribed by doctor</td><td>33 (36%)</td><td>29 (31%)</td><td>13 (14%)</td><td> </td></tr></table>
379564ccef785d32822beefe78cc39a921df2dd2ae24f0034157cc072e8c5ee1.png
simple
<table><tr><td>Description</td><td>Example selected for inclusion</td></tr><tr><td>Promises (of reduced pain)</td><td><i>If I&#8217;m thinner/lose more weight then rejection and criticism won&#8217;t hurt so much.</i></td></tr><tr><td>Consolation</td><td><i>I may not be doing so well in some areas of my life but at least I&#8217;m thin.</i></td></tr><tr><td>Self-congratulations (on eating behaviour etc.)</td><td><i>I&#8217;m doing really well in controlling my eating today.</i></td></tr><tr><td>Threats</td><td><i>If I don&#8217;t keep my eating under control, I&#8217;m going to get obese and be rejected by everyone.</i></td></tr><tr><td>Cautions regarding eating</td><td><i>That food/eating situation is dangerous. I&#8217;m going to have to be really careful about what I eat.</i></td></tr><tr><td>Need to purge</td><td><i>I&#8217;m worried that I&#8217;ve eaten too much. I need to get rid of it by purging.</i></td></tr><tr><td>Need to exercise</td><td><i>I can&#8217;t afford to just sit around, I have to exercise more.</i></td></tr><tr><td>Self-disappointment (at ability to meet dietary ideals)</td><td><i>I&#8217;m so disappointed at myself: I&#8217;ve failed to live up to my dietary ideals again.</i></td></tr><tr><td>Self-abuse</td><td><i>I am so pathetic and useless. I have no discipline or self-control.</i></td></tr><tr><td>Self-punishment</td><td><i>Because I have failed to live up to my dietary ideals I deserve to be punished by denying myself food or exercising harder.</i></td></tr><tr><td>Self-criticism (lack of self-worth)</td><td><i>I&#8217;m such a failure. I try really hard to do well and make friends but I&#8217;m just not the type of person I want to be.</i></td></tr><tr><td>Comparisons (with others)</td><td><i>Look at her she&#8217;s so thin and she does it so easily. Why can&#8217;t I be like her?</i></td></tr><tr><td>Reinterpretations</td><td><i>When they say things like &#8220;you&#8217;re looking well&#8221;, what they&#8217;re really meaning is how much weight I&#8217;ve put on.</i></td></tr><tr><td>Sensory misperceptions</td><td><i>Just feel that stomach/Look at those thighs (etc.). I feel/look so fat/terrible.</i></td></tr><tr><td>Denial (of symptoms)</td><td><i>Feeling tired and/or cold doesn&#8217;t mean there&#8217;s anything wrong with me. I just have to be stronger.</i></td></tr><tr><td>Moral judgements</td><td><i>Practising self-restraint is an important virtue. I despise people who have no self-control.</i></td></tr><tr><td>Ruination of life</td><td><i>My concern about food and weight is threatening the other things I want to achieve/get out of life.</i></td></tr><tr><td>Weariness (of constantly thinking about food)</td><td><i>I&#8217;m so fed up of constantly thinking about food and what I eat.</i></td></tr><tr><td>Misery (of living with an ED)</td><td><i>Life is so miserable/lonely living like this.</i></td></tr><tr><td>Lost identity</td><td><i>I feel like I don&#8217;t really know who I am/what I stand for any more. I&#8217;ve lost touch with the real me.</i></td></tr><tr><td>Need for secrecy</td><td><i>People mustn&#8217;t find out the way I think or behave concerning food.</i></td></tr><tr><td>Rebellion</td><td><i>I&#8217;m fed up of trying to control what I eat. I&#8217;m just going to eat whatever and as much as I want!</i></td></tr><tr><td>Pride in ED</td><td><i>When I think about how self-controlled I am around food compared to the average person, I feel quite proud of what I can achieve.</i></td></tr><tr><td>Fear of life without ED</td><td><i>If I let go of my strict control and ideals around eating, I&#8217;m really quite frightened about what life would be like.</i></td></tr></table>
c3264388a04cbd37e2ad34640fa74e775dedd57fb0050bba4b4604a6d74f5748.png
simple
<table><tr><td></td><td>Random sample</td><td>Symptom sample</td><td>Total</td></tr><tr><td>Total RAV population N</td><td>708</td><td>427</td><td>1135</td></tr><tr><td>GA2LEN + RAV SPT N</td><td>54</td><td>36</td><td>90</td></tr><tr><td>RAV SPT only N</td><td>654</td><td>391</td><td>1044</td></tr><tr><td>Age (SD)</td><td>33.7 (7.0)</td><td>33.7 (7.1)</td><td>33.7 (7.1)</td></tr><tr><td>Female (%)</td><td>379 (53.5)</td><td>245 (57.4)</td><td>624 (55.0)</td></tr><tr><td>Asthma (%)</td><td>66 (9.3)</td><td>211 (49.4)</td><td>277 (24.4)</td></tr><tr><td>Rhinitis (%)</td><td>303 (42.8)</td><td>288 (67.5)</td><td>591 (52.1)</td></tr></table>
ffabe53a1e05f2dddb8785bf97ab36acd82aface19c34d8c494ccb57625a1b52.png
complex
<table><tr><td></td><td>Focus groups</td><td>Systematic review</td><td>Online user-generated content</td></tr><tr><td colspan="4">METHODS</td></tr><tr><td>Main approach</td><td>Eight focus groups (<i>n</i> = 74)</td><td>Searching of databases from the earliest date to October 2014</td><td>Analysis of 3,373 reader comments posted online in response to a news article on incentives</td></tr><tr><td></td><td><i>Inclusion criteria</i>: UK adults, aged 18+ years</td><td><i>Databases searched</i>: Medline; Embase; Web of Knowledge; CINAHL; PsycINFO; ASSIA; Sociological Abstracts; Scopus; The Philosopher&#8217;s Index; Cochrane Library; SSCI; IBSS</td><td><i>News article topic</i>: feasibility study of financial incentives for breastfeeding</td></tr><tr><td></td><td><i>Method</i>: face-to-face focus groups; audio-recorded; lasting on average 60 min</td><td><i>Inclusion criteria</i>: English language title Published in a peer-reviewed journal Explored acceptability of financial incentives for healthy behaviors Acceptability explored in the public, policy makers, potential recipients, and practitioners</td><td><i>Online news sites searched</i>: BBC; Guardian; Daily Mail; Telegraph; Independent; The Sun</td></tr><tr><td></td><td><i>Analytical approach</i>: thematic analysis using NVivo 10</td><td><i>Analytical approach</i>: thematic analysis using NVivo 10</td><td><i>Inclusion criteria</i>: popular websites defined as those that achieved an average monthly audience of at least five million unique viewers per month across laptop computers, desktop computers, and mobile devices in April and May 2013 <i>Analytical approach</i>: thematic analysis using NVivo 10</td></tr><tr><td colspan="4">RESULTS</td></tr><tr><td>Main themes</td><td>The nature of fair exchange</td><td>Fair exchange</td><td>Children are a lifestyle choice</td></tr><tr><td></td><td>Design and delivery of incentive schemes</td><td>Design and delivery</td><td>Financial incentives for breastfeeding are discriminatory and divisive</td></tr><tr><td></td><td>Effectiveness and cost-effectiveness</td><td>Effectiveness and cost-effectiveness</td><td>Creating a culture of entitlement</td></tr><tr><td></td><td>Recipients</td><td>Recipients</td><td>Financial incentives for breastfeeding are potentially insulting</td></tr><tr><td></td><td>Impact on individuals and wider society</td><td>Impact on individuals and wider society</td><td>Psychological impacts on recipients</td></tr><tr><td></td><td>&#8220;Other&#8221; issues</td><td></td><td>Effectiveness and cost-effectiveness</td></tr><tr><td></td><td></td><td></td><td>Generating initial motivation</td></tr><tr><td></td><td></td><td></td><td>Design and delivery</td></tr><tr><td></td><td></td><td></td><td>Informed choice</td></tr></table>
6b1d5df508e15d4c7bd229189c1d10c14e7ade66296e74051e8411ae8c84d624.png
simple
<table><tr><td>Interaction</td><td>Odds ratio</td><td>Lower 95% CI</td><td>Upper 95% CI</td></tr><tr><td>Model GP</td><td></td><td></td><td></td></tr><tr><td> age &#8805;60</td><td></td><td></td><td></td></tr><tr><td>low SES to high</td><td>1.84</td><td>1.54</td><td>2.20</td></tr><tr><td>middle SES to high</td><td>1.57</td><td>1.32</td><td>1.87</td></tr><tr><td> age&lt;60</td><td></td><td></td><td></td></tr><tr><td>low SES to high</td><td>0.99</td><td>0.89</td><td>1.09</td></tr><tr><td>middle SES to high</td><td>0.96</td><td>0.86</td><td>1.06</td></tr><tr><td> age &#8805;60 vs age&lt;60</td><td></td><td></td><td></td></tr><tr><td>low SES</td><td>4.46</td><td>3.93</td><td>5.05</td></tr><tr><td>middle SES</td><td>3.91</td><td>3.45</td><td>4.44</td></tr><tr><td>high SES</td><td>2.39</td><td>2.04</td><td>2.80</td></tr><tr><td>Model SD</td><td></td><td></td><td></td></tr><tr><td> age &#8805;60</td><td></td><td></td><td></td></tr><tr><td>low SES to high</td><td>1.05</td><td>0.83</td><td>1.33</td></tr><tr><td>middle SES to high</td><td>1.08</td><td>0.86</td><td>1.35</td></tr><tr><td> age&lt;60</td><td></td><td></td><td></td></tr><tr><td>low SES to high</td><td>0.48</td><td>0.41</td><td>0.56</td></tr><tr><td>middle SES to high</td><td>0.78</td><td>0.68</td><td>0.90</td></tr><tr><td> age &#8805;60 to age&lt;60</td><td></td><td></td><td></td></tr><tr><td>low SES</td><td>4.66</td><td>3.85</td><td>5.65</td></tr><tr><td>middle SES</td><td>2.93</td><td>2.47</td><td>3.49</td></tr><tr><td>high SES</td><td>2.13</td><td>1.75</td><td>2.60</td></tr></table>
9754b3d106d0bc59dbbc6a2fb2b01ab3aefb028a1cd9743ad616dc41bcbf366d.png
simple
<table><tr><td>Ebolavirus</td><td>IgM+</td><td>IgG+</td><td>Reference</td></tr><tr><td>SUDV</td><td>2/3 (67%)</td><td>2/3 (67%)</td><td>[67]</td></tr><tr><td>SUDV</td><td>NR</td><td>6/27 (22%)</td><td>[68]</td></tr><tr><td>EBOV</td><td>3/7 (43%)</td><td>4/7 (57%)</td><td>[66]</td></tr><tr><td>EBOV</td><td>1/3 (33%)</td><td>0/3 (0%)</td><td>[40]</td></tr><tr><td>Total SUDV</td><td>2/3 (67%)</td><td>8/30 (27%)</td><td></td></tr><tr><td>Total EBOV</td><td>4/10 (40%)</td><td>4/10 (40%)</td><td></td></tr><tr><td>Total Combined</td><td>6/13 (46%)</td><td>12/40 (30%)</td><td></td></tr></table>
41cae14533e0f1ddb13f2df405b190314d1b6d471b67c0588f13f8813eeec738.png
simple
<table><tr><td></td><td>All proteins</td><td>Human proteins</td></tr><tr><td>Total proteins</td><td>550,299</td><td>20,186</td></tr><tr><td>PTM proteins</td><td>112,985</td><td>13,080</td></tr><tr><td>PPI annotation (string)</td><td>326,227</td><td>17,833</td></tr><tr><td>PTM &amp; PPI proteins</td><td>65,907</td><td>12,541</td></tr><tr><td>Drug-binding proteins(DrugBank)</td><td>&#8211;</td><td>1980</td></tr><tr><td>PTM &amp; drug-binding proteins</td><td>&#8211;</td><td>1404</td></tr></table>
d5f3a2b76e39c569acdeb2d31032733860a945d6197b2243f6ca5ac8be2c6998.png
simple
<table><tr><td></td><td>xthr</td><td>xtbs</td><td>xthr and xtbs</td></tr><tr><td>Number of sequences reads obtained</td><td>30272</td><td>27602</td><td>57874</td></tr><tr><td>Number of clone sequences obtained</td><td>16548</td><td>14901</td><td>31449</td></tr><tr><td>Number of valid sequences</td><td>26440</td><td>22345</td><td>48785</td></tr><tr><td>Number of clones with valid sequences</td><td>15540</td><td>12266</td><td>27806</td></tr><tr><td>Number of clones with 5' and 3' EST</td><td>9354</td><td>11486</td><td>20840</td></tr><tr><td>Number of clones with 5' EST only</td><td>4831</td><td>0</td><td>4831</td></tr><tr><td>Number of clones with 3' EST only</td><td>1355</td><td>780</td><td>2135</td></tr><tr><td>Average trimmed EST length</td><td>522</td><td>546</td><td>534</td></tr><tr><td>Number of contigs</td><td>4327</td><td>4002</td><td>8756</td></tr><tr><td>Number of contigs groups</td><td>497</td><td>289</td><td>842</td></tr><tr><td>Number of contigs grouped</td><td>1210</td><td>649</td><td>2209</td></tr><tr><td>Number of unique contigs</td><td>3117</td><td>3353</td><td>6547</td></tr><tr><td>Nulmber of clones in contigs</td><td>9616</td><td>9268</td><td>15642</td></tr><tr><td>Number of singletons</td><td>7958</td><td>4262</td><td>17018</td></tr><tr><td>Number of clones in singletons</td><td>5924</td><td>2998</td><td>12164</td></tr><tr><td>Number of putative transcripts</td><td>9538</td><td>6640</td><td>19553</td></tr><tr><td>Max. assembled sequence length</td><td>3028</td><td>3144</td><td>3028</td></tr><tr><td>Average assembled sequence length</td><td>732</td><td>782</td><td>745</td></tr><tr><td>Max. assembled sequence size</td><td>147</td><td>144</td><td>159</td></tr><tr><td>Average assembled sequence size</td><td>6</td><td>5</td><td>5</td></tr><tr><td>Number of contigs containing</td><td></td><td></td><td></td></tr><tr><td>1</td><td>509</td><td>97</td><td>1152</td></tr><tr><td>2</td><td>1779</td><td>2155</td><td>3730</td></tr><tr><td>3</td><td>452</td><td>362</td><td>905</td></tr><tr><td>4&#8211;5</td><td>587</td><td>545</td><td>1159</td></tr><tr><td>6&#8211;10</td><td>505</td><td>476</td><td>952</td></tr><tr><td>11&#8211;20</td><td>283</td><td>207</td><td>479</td></tr><tr><td>21&#8211;30</td><td>91</td><td>90</td><td>174</td></tr><tr><td>31&#8211;50</td><td>80</td><td>41</td><td>118</td></tr><tr><td>50&#8211;100</td><td>31</td><td>26</td><td>76</td></tr><tr><td>&gt;100</td><td>10</td><td>3</td><td>11</td></tr></table>
c2a49b8edd7d4cc3da78443a63686bcc9d4c9d00fed988e56b52ceec80018c67.png
simple
<table><tr><td> </td><td>N of articles</td></tr><tr><td>Exclusively women</td><td>15</td></tr><tr><td>Pregnant</td><td>8</td></tr><tr><td>Reproductive age/infertility evaluation</td><td>3</td></tr><tr><td>Postpartum</td><td>2</td></tr><tr><td>Others</td><td>2</td></tr><tr><td>Patients (men and women)</td><td>10</td></tr><tr><td>Inpatients</td><td>4</td></tr><tr><td>Primary care</td><td>3</td></tr><tr><td>Others</td><td>3</td></tr><tr><td>College students (men and women)</td><td>10</td></tr><tr><td>General population (men and women, online)</td><td>1</td></tr><tr><td>Total</td><td>36</td></tr></table>
6e89b09cf2c752fce96d97b3fcc766219cc0169f9061ae2b195831e529114eff.png
simple
<table><tr><td>Age group (years)</td><td>Total</td><td>RVID (cm)</td><td>PADP (mm Hg)</td><td>TRVel (m/s)</td><td>PASP (mm Hg)</td><td>TVI<sub>RVOT</sub> (cm)</td><td>PVCSA (cm<sup>2</sup>)</td><td>PBF (L/min)</td><td>PVR<sub>ECHO</sub> (Woods unit)</td></tr><tr><td>Study group</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>A (18 - 25)</td><td>30</td><td>2.92</td><td>10.4</td><td>2.20</td><td>192</td><td>24.7</td><td>3.56</td><td>6.73</td><td>1.04</td></tr><tr><td>B (26 - 32)</td><td>16</td><td>2.9</td><td>10</td><td>2.24</td><td>20.2</td><td>24.4</td><td>3.47</td><td>6.68</td><td>1.09</td></tr><tr><td>C (33 - 40)</td><td>14</td><td>3.10</td><td>10.9</td><td>2.26</td><td>20</td><td>24.36</td><td>3.57</td><td>6.65</td><td>1.08</td></tr><tr><td>Total</td><td>60</td><td>2.95</td><td>10.4</td><td>2.23</td><td>19.7</td><td>24.52</td><td>3.57</td><td>6.70</td><td>1.06</td></tr><tr><td>Control group</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>A (18 - 25)</td><td>8</td><td>2.80</td><td>10.3</td><td>1.94</td><td>16.7</td><td>20.7</td><td>3.49</td><td>5.22</td><td>1.20</td></tr><tr><td>B (26 - 32)</td><td>4</td><td>2.84</td><td>9.9</td><td>2.2</td><td>19.4</td><td>20.9</td><td>3.52</td><td>5.23</td><td>1.28</td></tr><tr><td>C (33 - 40)</td><td>3</td><td>2.8</td><td>10.2</td><td>2.4</td><td>23.4</td><td>20.8</td><td>3.53</td><td>5.19</td><td>1.30</td></tr><tr><td>Total</td><td>15</td><td>2.8</td><td>10.2</td><td>2.16</td><td>19.1</td><td>20.7</td><td>3.52</td><td>5.22</td><td>1.22</td></tr></table>
a7e14f8c3cd654b72663db8f506ab3f1919f295fe828d214fa2d2802f0bb9ca3.png
simple
<table><tr><td>Against</td><td>For</td></tr><tr><td>Mutilates healthy organCauses psychological distressInflicts a woundDestroys ability to be fruitfulViolates prohibition against castration</td><td>Prolongs life</td></tr></table>
8f918548fbff56eb53cff6e2208e523ef7e453259f57d29228e8199724ddf1a0.png
complex
<table><tr><td colspan="9">Probabilities for <i>Post Hoc</i> Tests Error: Between MS = 13.662, df = 4,314.0</td></tr><tr><td></td><td>Fan</td><td>Fan blades position</td><td>{1}</td><td>{2}</td><td>{3}</td><td>{4}</td><td>{5}</td><td>{6}</td></tr><tr><td>{1}</td><td>B</td><td>1.5</td><td></td><td>0.062871</td><td>0.123359</td><td>0.000020</td><td>0.000020</td><td>0.000020</td></tr><tr><td>{2}</td><td>B</td><td>3</td><td>0.062871</td><td></td><td>0.999825</td><td>0.000063</td><td>0.000020</td><td>0.000020</td></tr><tr><td>{3}</td><td>B</td><td>4.5</td><td>0.123359</td><td>0.999825</td><td></td><td>0.000031</td><td>0.000020</td><td>0.000020</td></tr><tr><td>{4}</td><td>B+F</td><td>1.5</td><td>0.000020</td><td>0.000063</td><td>0.000031</td><td></td><td>0.000189</td><td>0.000046</td></tr><tr><td>{5}</td><td>B+F</td><td>3</td><td>0.000020</td><td>0.000020</td><td>0.000020</td><td>0.000189</td><td></td><td>0.998916</td></tr><tr><td>{6}</td><td>B+F</td><td>4.5</td><td>0.000020</td><td>0.000020</td><td>0.000020</td><td>0.000046</td><td>0.998916</td><td></td></tr></table>
2fb46b7e2ed38a6a3168f06517e1e7926f854ab68762b6e2c90c6ddc9b0ed2dc.png
simple
<table><tr><td>Models</td><td>CoP (FIG, 2009)</td><td>Model A</td><td>Model B</td><td>Model C</td><td>Model D</td><td>Model E</td></tr><tr><td>R</td><td>.842<sup>(a)</sup></td><td>.799<sup>(a)</sup></td><td>.977<sup>(a)</sup></td><td>.792<sup>(a)</sup></td><td>.888<sup>(a)</sup></td><td>.888<sup>(a)</sup></td></tr><tr><td>R<sup>2</sup></td><td>.709</td><td>.638</td><td>.955</td><td>.628</td><td>.788</td><td>.788</td></tr><tr><td>Adjusted R<sup>2</sup></td><td>.689</td><td>.614</td><td>.952</td><td>.603</td><td>.774</td><td>774</td></tr><tr><td>Std. E. of the Estimate</td><td>.762</td><td>1.901</td><td>.468</td><td>.298</td><td>43.161</td><td>17.217</td></tr><tr><td>&#916;R<sup>2</sup></td><td>.709</td><td>.638</td><td>.955</td><td>.628</td><td>.788</td><td>788</td></tr><tr><td>&#916;F</td><td>35.948</td><td>26.036</td><td>310.568</td><td>24.896</td><td>54.809</td><td>54.920</td></tr><tr><td>df1</td><td>4</td><td>4</td><td>4</td><td>4</td><td>4</td><td>4</td></tr><tr><td>df2</td><td>59</td><td>59</td><td>59</td><td>59</td><td>59</td><td>59</td></tr><tr><td>p</td><td>.000</td><td>.000</td><td>.000</td><td>.000</td><td>.000</td><td>.000</td></tr></table>
3a098b94bc1b9fc5c03ae3e48148bd67eb1b3884f8db14f77f8b5a198ab3c954.png
simple
<table><tr><td></td><td>Consistent** increased brain activation across ROI&#8217;s after treatment (<i>n</i> = 6)</td><td>Consistent** decrease (or unchanged) brain activation across ROIs after treatment (<i>n</i> = 7)</td><td>Mixed neuroplastic pattern across ROIs after treatment (<i>n</i> = 10)</td><td><i>p</i> value*</td></tr><tr><td>AMAT at baseline (s), mean (SD)</td><td>1691.6(479)</td><td>1070.5(753)</td><td>2041.7(349)</td><td>0.04</td></tr><tr><td>AMAT improvement (s), mean (SD)</td><td>693.3(471)</td><td>169.8 (203)</td><td>430(309)</td><td>0.02</td></tr><tr><td>Age in years, mean(SD)</td><td>58.17(6.8)</td><td>57.57 (13.6)</td><td>51.7(14.6)</td><td>ns</td></tr><tr><td>Time since stroke, in years, mean(SD)</td><td>2.28(1.5)</td><td>1.99 (1.3)</td><td>1.34(0.4)</td><td>ns</td></tr></table>
8a8605a71aa3d929465921d6355b5f2336c74f74fc9f32a02d4c551bde01801a.png
complex
<table><tr><td></td><td colspan="2">Patients who underwent a given number of invasive diagnostic procedures (%)</td></tr><tr><td></td><td>RIC (<i>N</i> = 195)</td><td>Non-RIC (<i>N</i> = 132)</td></tr><tr><td>Total number of invasive diagnostic procedures performed</td><td></td><td></td></tr><tr><td>0<sup>a</sup></td><td>9 (5)</td><td>10 (8)</td></tr><tr><td>1</td><td>99 (51)</td><td>68 (51)</td></tr><tr><td>2</td><td>67 (34)</td><td>41 (31)</td></tr><tr><td>&#8805;3</td><td>20 (10)</td><td>13 (9)</td></tr></table>
b2d404312c5dad84adf8b377df3aa28ce9deb72c21a0f3615f1e117d180f608b.png
complex
<table><tr><td></td><td></td><td colspan="6">All individuals</td></tr><tr><td>Age groups</td><td></td><td>2&#8211;3 years</td><td>4&#8211;8 years</td><td>9&#8211;18 years</td><td>19&#8211;50 years</td><td>51&#8211;70 years</td><td>71+ years</td></tr><tr><td rowspan="2">Total dairy, cup/equivalents</td><td>Current</td><td>2.38 &#177; 0.11</td><td>2.04 &#177; 0.05</td><td>2.05 &#177; 0.06</td><td>1.65 &#177; 0.04</td><td>1.46 &#177; 0.04</td><td>1.28 &#177; 0.03</td></tr><tr><td>Modeled</td><td>2.43 &#177; 0.10</td><td>2.39 &#177; 0.04</td><td>3.00 &#177; 0.04</td><td>3.03 &#177; 0.03</td><td>2.99 &#177; 0.03</td><td>2.91 &#177; 0.02</td></tr><tr><td rowspan="2">Calcium, mg/d</td><td>Current</td><td>1037 &#177; 35</td><td>975 &#177; 17</td><td>1047 &#177; 21</td><td>1025 &#177; 15</td><td>933 &#177; 14</td><td>814 &#177; 13</td></tr><tr><td>Modeled</td><td>1054 &#177; 34</td><td>1081 &#177; 15</td><td>1329 &#177; 16</td><td>1436 &#177; 12</td><td>1387 &#177; 11</td><td>1300 &#177; 11</td></tr><tr><td rowspan="2">Magnesium, mg/d</td><td>Current</td><td>200 &#177; 4</td><td>211 &#177; 2</td><td>247 &#177; 4</td><td>307 &#177; 5</td><td>302 &#177; 4</td><td>256 &#177; 4</td></tr><tr><td>Modeled</td><td>201 &#177; 4</td><td>218 &#177; 2</td><td>266 &#177; 4</td><td>335 &#177; 5</td><td>332 &#177; 4</td><td>289 &#177; 4</td></tr><tr><td rowspan="2">Protein, g/d</td><td>Current</td><td>53.3 &#177; 1.2</td><td>59.4 &#177; 0.7</td><td>75.2 &#177; 1.2</td><td>87.2 &#177; 1.0</td><td>79.3 &#177; 1.1</td><td>64.3 &#177; 1.2</td></tr><tr><td>Modeled</td><td>53.7 &#177; 1.2</td><td>62.5 &#177; 0.6</td><td>83.3 &#177; 1.1</td><td>98.9 &#177; 0.9</td><td>92.2 &#177; 1.1</td><td>78.1 &#177; 1.1</td></tr><tr><td rowspan="2">Vitamin A, RAE/d</td><td>Current</td><td>581 &#177; 15</td><td>579 &#177; 11</td><td>598 &#177; 18</td><td>599 &#177; 13</td><td>664 &#177; 12</td><td>658 &#177; 17</td></tr><tr><td>Modeled</td><td>587 &#177; 15</td><td>615 &#177; 11</td><td>692 &#177; 16</td><td>736 &#177; 12</td><td>815 &#177; 11</td><td>819 &#177; 16</td></tr><tr><td rowspan="2">Vitamin D, &#956;g/d</td><td>Current</td><td>7.1 &#177; 0.2</td><td>5.8 &#177; 0.1</td><td>5.3 &#177; 0.1</td><td>4.7 &#177; 0.1</td><td>4.9 &#177; 0.1</td><td>4.7 &#177; 0.1</td></tr><tr><td>Modeled</td><td>7.2 &#177; 0.2</td><td>6.4 &#177; 0.1</td><td>6.7 &#177; 0.1</td><td>6.8 &#177; 0.1</td><td>7.3 &#177; 0.1</td><td>7.2 &#177; 0.1</td></tr><tr><td rowspan="2">Potassium, mg/d</td><td>Current</td><td>2035 &#177; 37</td><td>2049 &#177; 23</td><td>2261 &#177; 42</td><td>2705 &#177; 36</td><td>2799 &#177; 38</td><td>2457 &#177; 39</td></tr><tr><td>Modeled</td><td>2049 &#177; 37</td><td>2134 &#177; 23</td><td>2485 &#177; 39</td><td>3031 &#177; 34</td><td>3160 &#177; 36</td><td>2843 &#177; 37</td></tr><tr><td rowspan="2">Calories, kcal/d</td><td>Current</td><td>1456 &#177; 23</td><td>1728 &#177; 16</td><td>2088 &#177; 24</td><td>2276 &#177; 22</td><td>2011 &#177; 20</td><td>1649 &#177; 27</td></tr><tr><td>Modeled</td><td>1460 &#177; 23</td><td>1757 &#177; 15</td><td>2164 &#177; 24</td><td>2388 &#177; 21</td><td>2135 &#177; 20</td><td>1781 &#177; 26</td></tr><tr><td rowspan="2">Saturated Fat, g/d</td><td>Current</td><td>19.2 &#177; 0.6</td><td>22.3 &#177; 0.4</td><td>26.6 &#177; 0.4</td><td>28.0 &#177; 0.4</td><td>25.5 &#177; 0.4</td><td>20.2 &#177; 0.4</td></tr><tr><td>Modeled</td><td>19.3 &#177; 0.6</td><td>22.7 &#177; 0.4</td><td>27.5 &#177; 0.4</td><td>29.1 &#177; 0.4</td><td>26.9 &#177; 0.4</td><td>21.7 &#177; 0.4</td></tr><tr><td rowspan="2">Sodium, mg/d</td><td>Current</td><td>2113 &#177; 44</td><td>2617 &#177; 37</td><td>3392 &#177; 70</td><td>3742 &#177; 39</td><td>3375 &#177; 46</td><td>2717 &#177; 52</td></tr><tr><td>Modeled</td><td>2124 &#177; 44</td><td>2681 &#177; 37</td><td>3563 &#177; 69</td><td>3992 &#177; 37</td><td>3651 &#177; 45</td><td>3013 &#177; 51</td></tr></table>
7a7cda66c4423a01b30899a449da71c34bb6dda3fa6f96dcf1e0f46b6375d2c6.png
complex
<table><tr><td></td><td></td><td colspan="3">Spontaneous deliveries<sup>a</sup></td><td colspan="3">Provider-initiated deliveries</td><td colspan="3">All deliveries</td></tr><tr><td></td><td>Gestation length<sup>b</sup></td><td>Late preterm</td><td>Early term</td><td>Full term (reference)</td><td>Late preterm</td><td>Early term</td><td>Full term (reference)</td><td>Late preterm</td><td>Early term</td><td>Full term (reference)</td></tr><tr><td></td><td>N</td><td>1812</td><td>9701</td><td>56 527</td><td>1 007</td><td>4535</td><td>7824</td><td>2819</td><td>14054</td><td>64351</td></tr><tr><td>Unadjusted analyses</td><td></td><td>OR (95% CI)<sup>c</sup></td><td>OR (95% CI)</td><td>OR (95% CI)</td><td>OR (95% CI)</td><td>OR (95% CI)</td><td>OR (95% CI)</td><td>OR (95% CI)</td><td>OR (95% CI)</td><td>OR (95% CI)</td></tr><tr><td>Anxiety groups<sup>d</sup></td><td>Very high</td><td>1.5 (1.1-2.0)</td><td>1.3 (1.2-1.5)</td><td>-</td><td>1.7 (1.2-2.3)</td><td>1.3 (1.0-1.6)</td><td>-</td><td>1.8 (1.4-2.2)</td><td>1.4 (1.3-1.6)</td><td>-</td></tr><tr><td></td><td>High</td><td>1.2 (0.9-1.6)</td><td>1.0 (0.9-1.2)</td><td>-</td><td>0.9 (0.6-1.2)</td><td>1.0 (0.9-1.3)</td><td>-</td><td>1,2 (1.0-1.5)</td><td>1.1 1.0-1.2)</td><td>-</td></tr><tr><td></td><td>Low</td><td>1.2 (1.1-1.4)</td><td>1.1 (1.0-1.1)</td><td>-</td><td>1.1 (1.0-1.3)</td><td>1.1 (1.0-1.2)</td><td>-</td><td>1.2 (1.2-1.4)</td><td>1.1 (1.1-1.2)</td><td>-</td></tr><tr><td></td><td>Very low (reference)</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Adjusted analyses</td><td></td><td>OR (95% CI)</td><td>OR (95% CI)</td><td>OR (95% CI)</td><td>OR (95% CI)</td><td>OR (95% CI)</td><td>OR (95% CI)</td><td>OR (95% CI)</td><td>OR (95% CI)</td><td>OR (95% CI)</td></tr><tr><td>Anxiety groups</td><td>Very high</td><td>1.4 (1.0-1.8)</td><td>1.3 (1.1-1.5)</td><td>-</td><td>1.7 (1.2-2.4)</td><td>1.3 (1.0-1.6)</td><td>-</td><td>1.7 (1.3-2.0)</td><td>1.4 (1.3-1.6)</td><td>-</td></tr><tr><td></td><td>High</td><td>1.1 (0.9-1.5)</td><td>1.0 (0.9-1.1)</td><td>-</td><td>0.9 (0.6-1.3)</td><td>1.0 (0.9-1.3)</td><td>-</td><td>1.1 (0.9-1-4)</td><td>1.1 (1.0-1.2)</td><td>-</td></tr><tr><td></td><td>Low</td><td>1.2 (1.0-1.3)</td><td>1.0 (1.0-1.1)</td><td>-</td><td>1.1 (1.0-1.2)</td><td>1.1 (1.0-1.2)</td><td>-</td><td>1.2 (1.1-1.3)</td><td>1.1 (1.1-1.2)</td><td>-</td></tr><tr><td></td><td>Very low (reference)</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr></table>
e7baaa99d35af0b93ca2fc96eef0d935ccf42c5399cb78a079233a14119f17de.png
simple
<table><tr><td>Author</td><td>Country (ethnicity)</td><td>Cases/controls</td><td>Diagnosis of cases</td><td>Selection of controls</td></tr><tr><td>Selvaraj</td><td>India (Asian)</td><td>210/120</td><td>Smear, culture, radiological, clinical response confirmed PTB</td><td>Normal healthy spouses and Tuberculosis Research Centre staff, ethnicity and area of residence matched</td></tr><tr><td>Fitness</td><td>Malawi (African)</td><td>181/533</td><td>Smear, culture, histology confirmed TB, HIV negative</td><td>No history or symptom of TB; not first or second degree relatives of the cases; age, sex and area of residence matched</td></tr><tr><td>Vejbaesya</td><td>Thailand (Asian)</td><td>149/147</td><td>Smear, culture, clinical and radiological response confirmed PTB, HIV negative</td><td>Unrelated healthy blood bank donors</td></tr><tr><td>Ates</td><td>Turkey (Caucasian)</td><td>128/80</td><td>Smear, culture, pathological, radiological , clinical response confirmed PTB,EPTB</td><td>No history of TB noted on chest radiography, age and sex matched</td></tr><tr><td>Trajkov</td><td>Republic of Macedonia (Caucasian)</td><td>75/301</td><td>Smear/culture confirmed PTB</td><td>No family history of TB, nationality and area of residence matched</td></tr><tr><td>Merza</td><td>Iran (Asian)</td><td>117/60</td><td>Smear and radiological confirmed PTB</td><td>Nurses, doctors and TB staff with no laboratory or clinical sign of diseases development, age, sex and nationality matched</td></tr><tr><td>Sharma</td><td>India (Asian)</td><td>185/155</td><td>Smear, culture, histology, radiological , clinical response confirmed PTB,EPTB,HIV negative without chronic illness</td><td>Without a family history of TB or any other related disease and a possibility of a latent tuberculosis infection, socioeconomic status and ethnicity matched</td></tr><tr><td>Anoosheh</td><td>Iran (Asian)</td><td>93/103</td><td>Smear and culture confirmed PTB</td><td>No history of TB</td></tr><tr><td>Lin</td><td>China (Asian)</td><td>46/40</td><td>Pathological examination and clinical response confirmed EPTB</td><td>NR</td></tr></table>
e7885570bb544fc36da51cf17a81aa341da5f5f43efad40bb3a6dbb6a18fb293.png
complex
<table><tr><td rowspan="2">Molecular species</td><td colspan="2">4 months</td><td colspan="2">10 months</td><td colspan="2">15 months</td></tr><tr><td>Fold Changes <sup>1</sup></td><td><i>p</i>-value <sup>2</sup></td><td>Fold Changes <sup>1</sup></td><td><i>p</i>-value <sup>2</sup></td><td>Fold Changes <sup>1</sup></td><td><i>p</i>-value <sup>2</sup></td></tr><tr><td colspan="7"><i>Metabolites derived from arachidonic acid</i></td></tr><tr><td> Prostaglandin D<sub>2</sub></td><td>0.99</td><td>0.941</td><td>0.46</td><td>&lt; 0.001***</td><td>0.63</td><td>0.059</td></tr><tr><td> Thromboxane B<sub>2</sub></td><td>1.24</td><td>0.113</td><td>0.66</td><td>0.013*</td><td>1.07</td><td>0.845</td></tr><tr><td> 12-HHT</td><td>1.19</td><td>0.149</td><td>0.67</td><td>0.005**</td><td>0.98</td><td>0.952</td></tr><tr><td> 12-HETE</td><td>0.90</td><td>0.777</td><td>1.77</td><td>0.049*</td><td>1.03</td><td>0.931</td></tr><tr><td> 15-HETE</td><td>1.03</td><td>0.747</td><td>0.71</td><td>&lt;0.001***</td><td>0.87</td><td>0.604</td></tr><tr><td> 11,12-EpETrE</td><td>0.84</td><td>0.225</td><td>0.83</td><td>0.007**</td><td>1.04</td><td>0.886</td></tr><tr><td> 14,15-EpETrE</td><td>0.85</td><td>0.053</td><td>0.79</td><td>0.029*</td><td>0.97</td><td>0.810</td></tr><tr><td colspan="7"><i>Metabolites derived from eicosapentaenoic acid</i></td></tr><tr><td> 17,18-diHETE</td><td>2.12</td><td>&lt; 0.001***</td><td>1.10</td><td>0.602</td><td>1.42</td><td>0.300</td></tr><tr><td colspan="7"><i>Metabolites derived from docosahexaenoic acid</i></td></tr><tr><td> 19,20-diHDoPE</td><td>1.72</td><td>0.002**</td><td>1.20</td><td>0.251</td><td>1.38</td><td>0.261</td></tr></table>
60281663a33acbdb9f4119d0010a74b0ca53dcce250da2bdd9a5ff028d2fa8bf.png
simple
<table><tr><td></td><td>Matchsticks (%)</td><td>Nine-dot (%)</td><td>Eight-coin (%)</td></tr><tr><td>s_inc+</td><td></td><td></td><td></td></tr><tr><td>Initial</td><td>40.0 &#177; 11.2</td><td>0.0 &#177; 0.0</td><td>5.0 &#177; 5.0</td></tr><tr><td>Retest</td><td>66.7 &#177; 14.2</td><td>36.8 &#177; 11.4</td><td>21.1 &#177; 9.6</td></tr><tr><td>s_inc-</td><td></td><td></td><td></td></tr><tr><td>Initial</td><td>39.0 &#177; 11.8</td><td>9.0 &#177; 9.1</td><td>0.0 &#177; 0.0</td></tr><tr><td>Retest</td><td>72.7 &#177; 14.1</td><td>20.0 &#177; 13.3</td><td>33.3 &#177; 11.4</td></tr><tr><td>w_inc+</td><td></td><td></td><td></td></tr><tr><td>Initial</td><td>48.0 &#177; 11.2</td><td>10 &#177; 6.6</td><td>10.0 &#177; 6.6</td></tr><tr><td>Retest</td><td>90.9 &#177; 9.1</td><td>26.3 &#177; 10.4</td><td>42.1 &#177; 11.6</td></tr><tr><td>w_inc-</td><td></td><td></td><td></td></tr><tr><td>Initial</td><td>56.0 &#177; 12.1</td><td>6.0 &#177; 5.9</td><td>17.0 &#177; 9.0</td></tr><tr><td>Retest</td><td>87.5 &#177; 12.5</td><td>31.3 &#177; 12.0</td><td>33.3 &#177; 12.6</td></tr></table>
50b6710ed26b6a3f777ff2e2e990ac74bf2ebea60f93523499d9ff99123bce0d.png
complex
<table><tr><td> </td><td colspan="2">PLR &lt; 160</td><td colspan="2">PLR &#8805; 160</td><td><i>p</i></td></tr><tr><td> </td><td>No.</td><td><i>%</i></td><td>No.</td><td><i>%</i></td><td> </td></tr><tr><td>Age</td><td> </td><td> </td><td> </td><td> </td><td>0.756</td></tr><tr><td>&lt; 60 years</td><td>54</td><td>49.5</td><td>55</td><td>50.5</td><td> </td></tr><tr><td>&#8805; 60 years</td><td>34</td><td>52.3</td><td>31</td><td>47.7</td><td> </td></tr><tr><td>Gender</td><td> </td><td> </td><td> </td><td> </td><td>0.011</td></tr><tr><td>Male</td><td>66</td><td>57.9</td><td>48</td><td>42.1</td><td> </td></tr><tr><td>Female</td><td>22</td><td>36.7</td><td>38</td><td>63.3</td><td> </td></tr><tr><td>Previous operation</td><td> </td><td> </td><td> </td><td> </td><td>0.004</td></tr><tr><td>+</td><td>68</td><td>58.6</td><td>48</td><td>41.4</td><td> </td></tr><tr><td>-</td><td>20</td><td>34.5</td><td>38</td><td>65.5</td><td> </td></tr><tr><td>Adjuvant chemotherapy</td><td> </td><td> </td><td> </td><td> </td><td>&lt; 0.001</td></tr><tr><td>+</td><td>49</td><td>66.2</td><td>25</td><td>33.8</td><td> </td></tr><tr><td>-</td><td>39</td><td>39.0</td><td>61</td><td>70.9</td><td> </td></tr><tr><td>Lauren&#8217;s classification</td><td> </td><td> </td><td> </td><td> </td><td>0.078</td></tr><tr><td>Diffuse</td><td>20</td><td>50.0</td><td>20</td><td>50.0</td><td> </td></tr><tr><td>Intestinal</td><td>14</td><td>56.0</td><td>11</td><td>44.0</td><td> </td></tr><tr><td>Mixed</td><td>42</td><td>44.7</td><td>52</td><td>55.3</td><td> </td></tr><tr><td>Unknown</td><td>12</td><td>80.0</td><td>3</td><td>20.0</td><td> </td></tr><tr><td>CEA</td><td> </td><td> </td><td> </td><td> </td><td>0.195</td></tr><tr><td>&lt; 5 ng/ml</td><td>64</td><td>54.2</td><td>54</td><td>45.8</td><td> </td></tr><tr><td>&#8805; 5 ng/ml</td><td>24</td><td>42.9</td><td>32</td><td>57.1</td><td> </td></tr><tr><td>Number of metastasis</td><td> </td><td> </td><td> </td><td> </td><td>0.070</td></tr><tr><td>1</td><td>42</td><td>44.2</td><td>53</td><td>55.8</td><td> </td></tr><tr><td>&gt; 1</td><td>46</td><td>58.2</td><td>33</td><td>41.8</td><td> </td></tr></table>
66700e8b68a638cec5187216c393022800dbf1916072a072dbe3ee16924d913b.png
complex
<table><tr><td rowspan="2">Demographics</td><td colspan="4">Estimated glomerular filtration rates (mL/min/1.73 m<sup>2</sup>)</td><td rowspan="2">P</td></tr><tr><td>&lt; 60</td><td>&#8805; 60 - &lt; 90</td><td>&#8805; 90 - 120</td><td>&#8805; 120</td></tr><tr><td>Patient no., n (%)</td><td>72 (8.1)</td><td>390 (44.1)</td><td>345 (39)</td><td>77 (8.7)</td><td></td></tr><tr><td>Gender (F/M), n</td><td>20/52</td><td>53/337</td><td>30/315</td><td>8/69</td><td>&lt; 0.001</td></tr><tr><td>Age, years</td><td>59 &#177; 8.9</td><td>55.8 &#177; 8.3</td><td>51.1 &#177; 9</td><td>50.2 &#177; 8.5</td><td>&lt; 0.001</td></tr><tr><td>Smoking, n (%)</td><td>38 (52.7)</td><td>238 (61.1)</td><td>211 (60.3)</td><td>57 (74)</td><td>0.118</td></tr><tr><td>CAD, n (%)</td><td>9 (12.5)</td><td>80 (20.5)</td><td>56 (16.2)</td><td>14 (18.2)</td><td>0.262</td></tr><tr><td>Diabetes mellitus, n (%)</td><td>30 (41)</td><td>113 (29)</td><td>66 (19)</td><td>19 (24.6)</td><td>0.137</td></tr><tr><td>Hypertension, n (%)</td><td>49 (68)</td><td>169 (43.3)</td><td>103 (29.8)</td><td>23 (29%)</td><td>0.072</td></tr><tr><td>Follow-up, months</td><td>18.9 &#177; 16</td><td>21.8 &#177; 15.6</td><td>22.8 &#177; 14.1</td><td>22.1 &#177; 13</td><td>0.245</td></tr><tr><td>Hospitalization, days</td><td>9.2 &#177; 5.3</td><td>7.8 &#177; 4.4</td><td>7.1 &#177; 3.8</td><td>7.7 &#177; 4.6</td><td>0.004</td></tr><tr><td>eGFR</td><td>50.5 &#177; 9.2</td><td>76.7 &#177; 7.3</td><td>101.3 &#177; 8</td><td>134 &#177; 12.2</td><td>&lt; 0.001</td></tr><tr><td>Admission creatine, mg/dL</td><td>1.4 &#177; 0.4</td><td>1.03 &#177; 0.1</td><td>0.83 &#177; 0.07</td><td>0.67 &#177; 0.05</td><td>&lt; 0.001</td></tr><tr><td>CK-MB, U/L</td><td>310 &#177; 215</td><td>216 &#177; 182</td><td>231 &#177; 177</td><td>225 &#177; 186</td><td>&lt; 0.001</td></tr><tr><td>Leucocyte, 10<sup>3</sup>/&#956;L</td><td>14.5 &#177; 4.7</td><td>13 &#177; 4</td><td>12.7 &#177; 3.4</td><td>12.6 &#177; 3.1</td><td>0.004</td></tr><tr><td>Hemoglobin, mg/dL</td><td>13.9 &#177;1.3</td><td>14.2 &#177; 1.3</td><td>14.1 &#177; 1.1</td><td>14.2 &#177; 0.9</td><td>0.625</td></tr><tr><td>Admission glucose, mg/dL</td><td>203 &#177; 104</td><td>161 &#177; 75</td><td>147 &#177; 64</td><td>157 &#177; 88</td><td>&lt; 0.001</td></tr><tr><td>Potassium</td><td>4.4 &#177; 0.6</td><td>4.1 &#177; 0.5</td><td>4.1 &#177; 0.47</td><td>4.05 &#177; 0.49</td><td>&lt; 0.001</td></tr><tr><td>Stent diameter, mm</td><td>3.1 &#177; 0.37</td><td>3.13 &#177; 0.36</td><td>3.15 &#177; 0.32</td><td>3.06 &#177; 0.34</td><td>0.277</td></tr><tr><td>Stent length, cm</td><td>21.4 &#177; 9</td><td>19.5 &#177; 6.8</td><td>18.5 &#177; 6.2</td><td>20.4 &#177; 5.8</td><td>0.013</td></tr><tr><td>Ejection fraction, %</td><td>42.2 &#177; 12</td><td>48.2 &#177; 10.2</td><td>49.2 &#177; 10.1</td><td>51.1 &#177; 8.8</td><td>&lt; 0.001</td></tr></table>
c912d52ecf3a5f4d91f6d39a7238c404da900e733d64c96d764dad36acb8beec.png
complex
<table><tr><td>Socio&#8211;demographic characteristic</td><td><i>N</i></td><td>Per cent (95 % CI)</td></tr><tr><td colspan="3">Age group &#8211;</td></tr><tr><td> 11&#8211;15 years</td><td>53</td><td>3.3 (2.4&#8211;4.2)</td></tr><tr><td> 16&#8211;17 years</td><td>74</td><td>5.5 (4.3&#8211;6.7)</td></tr><tr><td colspan="3">Highest level of parent/carer education &#8211;</td></tr><tr><td> Bachelor degree or higher</td><td>54</td><td>4.7 (3.4&#8211;6.0)</td></tr><tr><td> Diploma or cert III/IV</td><td>44</td><td>3.0 (2.1&#8211;4.0)</td></tr><tr><td> Year 11 or 12</td><td>13</td><td>3.4 (1.5&#8211;5.3)</td></tr><tr><td> Year 10 or below</td><td>16</td><td>5.7 (2.7&#8211;8.6)</td></tr><tr><td colspan="3">Parent/carer labour force status &#8211;</td></tr><tr><td> Both carers employed</td><td>59</td><td>3.4 (2.5&#8211;4.3)</td></tr><tr><td> One carer employed, one carer not in employment</td><td>29</td><td>4.8 (2.8&#8211;6.8)</td></tr><tr><td> Both carers not in employment</td><td>7</td><td>8.7 (2.3&#8211;15.0)</td></tr><tr><td> Sole carer employed</td><td>24</td><td>3.9 (2.3&#8211;5.5)</td></tr><tr><td> Sole carer not in employment</td><td>8</td><td>3.5 (0.9&#8211;6.1)</td></tr><tr><td> Not stated</td><td>0</td><td>&#8211;</td></tr><tr><td colspan="3">Housing tenure &#8211;</td></tr><tr><td> Owned outright</td><td>12</td><td>2.5 (1.0&#8211;4.1)</td></tr><tr><td> Owned with a mortgage</td><td>65</td><td>3.5 (2.6&#8211;4.4)</td></tr><tr><td> Rented &#8211; public housing</td><td>9</td><td>6.5 (2.4&#8211;10.6)</td></tr><tr><td> Rented &#8211; other</td><td>41</td><td>5.3 (3.5&#8211;7.1)</td></tr><tr><td> Other</td><td>0</td><td>&#8211;</td></tr><tr><td colspan="3">Annual household income &#8211;</td></tr><tr><td> Less than $52,000</td><td>32</td><td>4.4 (2.8&#8211;6.0)</td></tr><tr><td> $52,000&#8211;129,000</td><td>54</td><td>3.6 (2.6&#8211;4.6)</td></tr><tr><td> $130,000 or more</td><td>37</td><td>4.3 (2.9&#8211;5.8)</td></tr><tr><td colspan="3">Child&#8217;s country of birth &#8211;</td></tr><tr><td> Australia</td><td>107</td><td>3.7 (3.0&#8211;4.5)</td></tr><tr><td> Overseas</td><td>20</td><td>5.0 (2.6&#8211;7.4)</td></tr><tr><td colspan="3">Family type &#8211;</td></tr><tr><td> Intact family</td><td>73</td><td>3.8 (2.9&#8211;4.7)</td></tr><tr><td> Step family</td><td>7</td><td>3.7 (0.7&#8211;6.7)</td></tr><tr><td> Blended family<sup>a</sup></td><td>11</td><td>4.4 (1.6&#8211;7.1)</td></tr><tr><td> Lone parent family</td><td>33</td><td>3.9 (2.5&#8211;5.3)</td></tr><tr><td> Other family</td><td>3</td><td>8.8 (0.00&#8211;18.8)</td></tr><tr><td colspan="3">Geographic level of remoteness &#8211;</td></tr><tr><td> Major cities</td><td>97</td><td>4.6 (3.6&#8211;5.5)</td></tr><tr><td> Inner regional Australia</td><td>22</td><td>2.8 (1.6&#8211;4.0)</td></tr><tr><td> Outer regional Australia</td><td>6</td><td>2.6 (0.2&#8211;5.0)</td></tr><tr><td> Remote Australia</td><td>2</td><td>3.7 (0.0&#8211;8.8)</td></tr></table>
21dff90c2a15d2eafdcff2c6500a39563a80cea033dd2a2bc707f29ec62509c2.png
simple
<table><tr><td>Feature</td><td>Description</td><td>Information gain</td></tr><tr><td>Feature 1</td><td>Number of neighbours in which the label is assigned</td><td>0.16</td></tr><tr><td>Feature 2</td><td>Sum of similarity scores between the document and all the neighbours&#8217; document where the label appears</td><td>0.17</td></tr><tr><td>Feature 3</td><td>Check whether all constituted tokens of the label appear in the target document</td><td>0.01</td></tr><tr><td>Feature 4</td><td>Check whether one of the label entries appears in the target document</td><td>0.03</td></tr><tr><td>Feature 5</td><td>Frequency of the label if it is contained in the document</td><td>0.03</td></tr><tr><td>Feature 6</td><td>Check if the label is contained in the document title</td><td>0.02</td></tr></table>
eb2f6e10107ba28bd8827a257b0cccc158ac864effca4ccdcb24eb64449cb66c.png
complex
<table><tr><td></td><td></td><td></td><td colspan="3">Larval temperature (&#176;C)</td></tr><tr><td></td><td>Adult temperature (&#176;C)</td><td></td><td>27 &#177; 1 (with respect to 23 &#176;C)</td><td>31 &#177; 1 (with respect to 23 &#176;C)</td><td>31 &#177; 1 (with respect to 27 &#176;C)</td></tr><tr><td rowspan="7">1<sup>st</sup> blood meal</td><td></td><td>Log odds of laying eggs</td><td>&#8722;0.783<sup>b</sup></td><td>&#8722;1.658</td><td>&#8722;0.876</td></tr><tr><td rowspan="2">23 &#177; 1</td><td>log-likelihood ratio test</td><td>&#8722;1.187</td><td>&#8722;2.455</td><td>&#8722;1.515</td></tr><tr><td><i>p</i>-value</td><td>0.235</td><td>0.014</td><td>0.130</td></tr><tr><td rowspan="3">27 &#177; 1</td><td>Log odds of laying eggs</td><td>&#8722;2.565</td><td>&#8722;4.069</td><td>&#8722;1.504</td></tr><tr><td>log-likelihood ratio test</td><td>&#8722;2.383</td><td>&#8722;3.828</td><td>&#8722;3.086</td></tr><tr><td><i>p</i>-value</td><td>0.017</td><td>&lt;0.001</td><td>0.002</td></tr><tr><td rowspan="3">31 &#177; 1</td><td>Log odds of laying eggs</td><td>0.767<sup>c</sup></td><td>&#8722;0.028</td><td>&#8722;0.795</td></tr><tr><td></td><td>log-likelihood ratio test</td><td>1.386</td><td>&#8722;0.048</td><td>&#8722;1.392</td></tr><tr><td></td><td><i>p</i>-value</td><td>0.166</td><td>0.962</td><td>0.164</td></tr><tr><td rowspan="9">2<sup>nd</sup> blood meal</td><td></td><td>Log odds of laying eggs</td><td>&#8722;1.952</td><td>&#8722;3.312</td><td>&#8722;1.36</td></tr><tr><td rowspan="2">23 &#177; 1</td><td>log-likelihood ratio test</td><td>&#8722;2.398</td><td>&#8722;3.805</td><td>&#8722;2.276</td></tr><tr><td><i>p</i>-value</td><td>0.016</td><td>&lt;0.001</td><td>0.023</td></tr><tr><td rowspan="3">27 &#177; 1</td><td>Log odds of laying eggs</td><td>&#8722;1.161</td><td>&#8722;2.496</td><td>&#8722;1.335</td></tr><tr><td>log-likelihood ratio test</td><td>&#8722;1.613</td><td>&#8722;3.486</td><td>&#8722;2.534</td></tr><tr><td><i>p</i>-value</td><td>0.107</td><td>&lt;0.001</td><td>0.011</td></tr><tr><td rowspan="3">31 &#177; 1</td><td>Log odds of laying eggs</td><td>1.121</td><td>0.359</td><td>&#8722;0.762</td></tr><tr><td>log-likelihood ratio test</td><td>1.557</td><td>0.465</td><td>&#8722;1.218</td></tr><tr><td><i>p</i>-value</td><td>0.120</td><td>0.642</td><td>0.223</td></tr></table>
bb9683092313c93f7c3bd7e34ce3ff3d40f813ed4fecb4ccf9fdcb3ecd635b55.png
simple
<table><tr><td>Sample</td><td>Layer thickness [nm] mean &#177; standard deviation</td></tr><tr><td>NCO-sP(EO-<i>stat</i>-PO) sample1</td><td>19.6 &#177; 0.4</td></tr><tr><td>NCO-sP(EO-<i>stat</i>-PO) sample2</td><td>24.4 &#177; 1.0</td></tr><tr><td>NCO-sP(EO-<i>stat</i>-PO) sample3</td><td>12.0 &#177; 0.8</td></tr></table>
81c587181851a9a59da336e1160ef158f2cafb818f9ff3be517d87e5d2e98a6e.png
simple
<table><tr><td>Doped Atoms X</td><td>Concentration (%)</td><td>Band Gap (eV)</td><td>CBM</td><td>VBM</td></tr><tr><td>-</td><td>0.00</td><td>1.59</td><td>&#915;</td><td>&#915;</td></tr><tr><td>S</td><td>1.56</td><td>1.52</td><td>&#915;</td><td>&#915;</td></tr><tr><td>S</td><td>2.78</td><td>1.48</td><td>&#915;</td><td>&#915;</td></tr><tr><td>S</td><td>6.25</td><td>1.43</td><td>&#915;</td><td>&#915;</td></tr><tr><td>O</td><td>6.25</td><td>1.54</td><td>Y</td><td>&#915;</td></tr><tr><td>Te</td><td>6.25</td><td>1.39</td><td>&#915;</td><td>&#915;</td></tr></table>
37cf43d2114e4e5f4343bf451f8dd97473207c222db6136b766b18bc97f5f5b1.png
complex
<table><tr><td rowspan="2"> </td><td>PTU-induced AAV</td><td>Primary AAV</td></tr><tr><td>(<i>n</i> = 17)</td><td>(<i>n</i> = 64)</td></tr><tr><td>Male/female</td><td>2/15</td><td>32/32</td></tr><tr><td>Age (years)</td><td>30.8 &#177; 15.2</td><td>60.48 &#177; 15.14</td></tr><tr><td>Scr (&#956;<i>M</i>)</td><td> </td><td> </td></tr><tr><td>Mean &#177; SD</td><td>75.62 &#177; 40.64</td><td>339.11 &#177; 237.71</td></tr><tr><td>Range</td><td>38-176.9</td><td>70-1007</td></tr><tr><td>Renal insufficiency at diagnosis</td><td>13 (76.4%)</td><td>48 (75%)</td></tr><tr><td>ESR (mm/1 hour)</td><td>46.92 &#177; 38.86</td><td>70.05 &#177; 40.14</td></tr><tr><td>Skin rash</td><td>5(29.4%)</td><td>7 (10.9%)</td></tr><tr><td>Arthralgia</td><td>9(52.9%)</td><td>15(23.4%)</td></tr><tr><td>Muscle pain</td><td>6 (35.3%)</td><td>10 (15.6%)</td></tr><tr><td>Lung</td><td>6 (35.3%)</td><td>43 (67.2%)</td></tr><tr><td>ENT</td><td>6 (35.2%)</td><td>27(42.2%)</td></tr><tr><td>Ophthalmic</td><td>2 (11.8%)</td><td>14(21.9%)</td></tr><tr><td>Gastrointestinal</td><td>3(17.6%)</td><td>11(17.2%)</td></tr><tr><td>Nervous system</td><td>1 (5.9%)</td><td>10(15.6%)</td></tr><tr><td>BVAS</td><td> </td><td> </td></tr><tr><td>Mean &#177; SD</td><td>17.1 &#177; 5.5</td><td>20.27 &#177; 5.18</td></tr><tr><td>Range</td><td>7-31</td><td>13-36</td></tr></table>
8ac40caef06ffd67d1813450c442df6762d00acd31287e0fd38371bad9241f4e.png
complex
<table><tr><td>PAHs</td><td colspan="2">Percentage (%)</td><td>PAHs</td><td colspan="2">Percentage (%)</td></tr><tr><td></td><td>Urban/agricultural soil</td><td>Forest soil</td><td></td><td>Urban/agricultural soil</td><td>Forest soil</td></tr><tr><td>Naphthalene</td><td>0.60-16.20</td><td>0.38-1.95</td><td>Benzo [a] anthracene</td><td>5.81-8.30</td><td>5.29-8.06</td></tr><tr><td>Acenaphthylene</td><td>0.13-0.45</td><td>0.06-0.71</td><td>Chrysene</td><td>5.34-11.57</td><td>10.01-12.71</td></tr><tr><td>Acenaphthene</td><td>0.69-12.17</td><td>0.73-2.45</td><td>Benzo [b] fluoranthene</td><td>4.87-6.21</td><td>6.98-10.27</td></tr><tr><td>Fluorene</td><td>0.58-5.19</td><td>0.47-2.26</td><td>Benzo [k] fluoranthene</td><td>3.27-4.07</td><td>3.40-4.56</td></tr><tr><td>Phenanthrene</td><td>4.44-9.26</td><td>4.79-9.44</td><td>Benzo [a] pyrene</td><td>5.20-7.62</td><td>6.27-9.83</td></tr><tr><td>Anthracene</td><td>0.79-1.45</td><td>0.74-1.79</td><td>Benzo [ghi] perylene</td><td>4.11-6.67</td><td>4.72-6.67</td></tr><tr><td>Fluoranthene</td><td>12.30-22.14</td><td>14.40-22.65</td><td>Dibenzo [a,h] anthracene</td><td>1.10-1.59</td><td>1.11-1.83</td></tr><tr><td>Pyrene</td><td>8.72-16.30</td><td>9.48-13.86</td><td>Indeno [1,2,3-cd] pyrene</td><td>7.67-12.62</td><td>8.76-13.34</td></tr></table>
e7bfdbc35f186372fc7d6eddaf455acfdde538ac3c0a64f766078881566524c6.png
simple
<table><tr><td><i>Clinical Characteristics</i></td><td><i>Mean (&#177;SD) or Frequency(%)</i></td></tr><tr><td>Mean Age in years</td><td>34.1&#177;13.01</td></tr><tr><td><i>Sex</i></td><td></td></tr><tr><td> Males</td><td>126 (60.3%)</td></tr><tr><td> Females</td><td>83 (39.7%)</td></tr><tr><td><i>Location of pain</i></td><td></td></tr><tr><td> Flank Pain</td><td>156 (75.4%)</td></tr><tr><td> Costovertebral angle pain</td><td>53 (24.6%)</td></tr><tr><td><i>Radiation</i></td><td></td></tr><tr><td> None</td><td>85 (48.8%)</td></tr><tr><td> Front</td><td>64 (30.6%)</td></tr><tr><td> Groin</td><td>50 (23.9%)</td></tr><tr><td> Genitalia</td><td>10 (4.7%)</td></tr><tr><td><i>Onset of pain</i></td><td></td></tr><tr><td> Sudden</td><td>100 (47.8%)</td></tr><tr><td> Gradual</td><td>109 (52.2%)</td></tr><tr><td><i>Severity of pain</i></td><td></td></tr><tr><td> Mild to Moderate</td><td>133 (63.6%)</td></tr><tr><td> Severe</td><td>76 (36.4%)</td></tr><tr><td><i>Pain Character</i></td><td></td></tr><tr><td> Colicky</td><td>122 (58.4%)</td></tr><tr><td> Continuous</td><td>87 (41.6%)</td></tr><tr><td><i>Urinary symptoms</i></td><td></td></tr><tr><td> None</td><td>56 (26.8%)</td></tr><tr><td> Dysuria</td><td>99 (47.4%)</td></tr><tr><td> Frequency/urgency</td><td>39 (18.7%)</td></tr><tr><td> Hematuria</td><td>15 (7.2%)</td></tr><tr><td><i>Systemic symptoms</i></td><td></td></tr><tr><td> None</td><td>90 (43.1%)</td></tr><tr><td> Nausea, vomiting</td><td>109 (52.2%)</td></tr><tr><td> Fever</td><td>10 (4.7%)</td></tr><tr><td><i>Aggravating factors</i></td><td></td></tr><tr><td> None</td><td>111 (53.1%)</td></tr><tr><td> Movement</td><td>67 (32.1%)</td></tr><tr><td> Rest</td><td>31 (14.8%)</td></tr><tr><td><i>Past history of renalstones</i></td><td></td></tr><tr><td> Yes</td><td>60 (28.8%)</td></tr><tr><td> No</td><td>149 (71.2%)</td></tr><tr><td><i>Findings on examination</i></td><td></td></tr><tr><td> None</td><td>152 (72.7%)</td></tr><tr><td> Costovertebral angle tenderness</td><td>57 (27.3%)</td></tr></table>
e656158a91c161768675f54c587269965e38a284f2e8264694a19d2073aa5238.png
complex
<table><tr><td>Primary site</td><td>N</td><td>HR</td><td colspan="2">95% CI</td></tr><tr><td><i>CUP (reference)</i></td><td>2881</td><td>1</td><td> </td><td> </td></tr><tr><td><i>Colorectal cancer</i></td><td>1438</td><td>0.61</td><td>0.57</td><td>0.65</td></tr><tr><td><i>Pancreatic cancer</i></td><td>460</td><td>1.71</td><td>1.54</td><td>1.90</td></tr><tr><td><i>Stomach cancer</i></td><td>322</td><td>1.16</td><td>1.02</td><td>1.31</td></tr><tr><td><i>Liver cancer</i></td><td>188</td><td>1.58</td><td>1.36</td><td>1.84</td></tr><tr><td><i>Lung cancer</i></td><td>2453</td><td>0.98</td><td>0.92</td><td>1.04</td></tr><tr><td><i>Kidney cancer</i></td><td>284</td><td>0.71</td><td>0.62</td><td>0.80</td></tr><tr><td><i>Bladder cancer</i></td><td>139</td><td>0.93</td><td>0.78</td><td>1.11</td></tr><tr><td><i>Prostate cancer</i></td><td>1259</td><td>0.24</td><td>0.22</td><td>0.26</td></tr><tr><td><i>Breast cancer</i></td><td>202</td><td>0.53</td><td>0.45</td><td>0.61</td></tr><tr><td><i>All known primaries</i></td><td>6745</td><td>0.69</td><td>0.66</td><td>0.72</td></tr></table>
e8b7fe317761b62276d9b750c6d95b2746088966cff863d815422fc3074882dd.png
simple
<table><tr><td>Sample name</td><td>Raw reads</td><td>Clean reads</td><td>Clean bases</td><td>Error rate (%)</td><td>Q20 (%)</td><td>Q30 (%)</td><td>GC content (%)</td></tr><tr><td>MT1</td><td>16301802</td><td>16084513</td><td>1.61G</td><td>0.03</td><td>97.25</td><td>91.76</td><td>43.5</td></tr><tr><td>MT2</td><td>14403818</td><td>14223118</td><td>1.42G</td><td>0.03</td><td>97.27</td><td>91.76</td><td>43.44</td></tr><tr><td>MT3</td><td>14197855</td><td>14025066</td><td>1.4G</td><td>0.03</td><td>97.31</td><td>91.87</td><td>43.53</td></tr><tr><td>WT1</td><td>13520581</td><td>13347784</td><td>1.33G</td><td>0.03</td><td>97.23</td><td>91.68</td><td>43.6</td></tr><tr><td>WT2</td><td>14715034</td><td>14532229</td><td>1.45G</td><td>0.03</td><td>97.29</td><td>91.82</td><td>43.49</td></tr><tr><td>WT3</td><td>15229307</td><td>15027468</td><td>1.5G</td><td>0.03</td><td>97.28</td><td>91.82</td><td>43.42</td></tr></table>
7d639a042dea7dd5ce02b4d5d09139932d8e46f97708f59d526edfa94bf5d877.png
complex
<table><tr><td rowspan="2">Name or code</td><td colspan="2">MIC (mg/L) [&#956;M]</td><td rowspan="2">GIC<sub>50</sub> RAW264.7 (mg/L) [&#956;M]</td><td rowspan="2">SI (=GIC<sub>50</sub>/MIC)</td><td rowspan="2">Mtb-MurE HPLC IC<sub>50</sub> (&#956;M)</td></tr><tr><td><i>M. bovis</i> BCG</td><td><i>M. tuberculosis</i> H<sub>37</sub>Rv</td></tr><tr><td>(<i>S</i>)-Leucoxine (1)</td><td>25 [70]</td><td>30 [84]</td><td>125 [352]</td><td>5.0</td><td>820</td></tr><tr><td>Norcoclaurine (2)</td><td>&gt;100 [&gt;369]</td><td>ND</td><td>425 [1566]</td><td>&lt;4.3</td><td>837</td></tr><tr><td>3</td><td>&gt;100 [&gt;392]</td><td>ND</td><td>81 [313]</td><td>&lt;0.81</td><td>ND</td></tr><tr><td>4</td><td>&gt;100 [&gt;413]</td><td>ND</td><td>60 [248]</td><td>&lt;0.60</td><td>ND</td></tr><tr><td>5</td><td>&gt;100 [&gt;369]</td><td>ND</td><td>91 [335]</td><td>&lt;0.91</td><td>ND</td></tr><tr><td>6</td><td>&gt;100 [&gt;389]</td><td>ND</td><td>92 [358]</td><td>&lt;0.92</td><td>ND</td></tr><tr><td>7</td><td>&gt;100 [&gt;389]</td><td>ND</td><td>88 [342]</td><td>&lt;0.88</td><td>ND</td></tr><tr><td>8</td><td>&gt;100 [&gt;389]</td><td>ND</td><td>87 [338]</td><td>&lt;0.87</td><td>ND</td></tr><tr><td>9</td><td>&gt;100 [&gt;404]</td><td>ND</td><td>56 [226]</td><td>&gt;0.56</td><td>ND</td></tr><tr><td>10</td><td>100 [271]</td><td>ND</td><td>&gt;250 [&gt;566]</td><td>&gt;2.5</td><td>ND</td></tr><tr><td>11</td><td>&gt;100 [&gt;334]</td><td>ND</td><td>87 [291]</td><td>&lt;0.87</td><td>ND</td></tr><tr><td>12</td><td>&gt;100 [&gt;342]</td><td>ND</td><td>&gt;250 [&gt;855]</td><td>ND</td><td>ND</td></tr><tr><td>13</td><td>100 [346]</td><td>ND</td><td>&gt;250 [&gt;864]</td><td>&gt;2.5</td><td>ND</td></tr><tr><td>14</td><td>&gt;100 [&gt;444]</td><td>ND</td><td>85 [377]</td><td>&lt;0.85</td><td>ND</td></tr><tr><td>15</td><td>&gt;100 [&gt;420]</td><td>ND</td><td>188 [789]</td><td>&lt;1.9</td><td>ND</td></tr><tr><td>16</td><td>100 [418]</td><td>ND</td><td>195 [683]</td><td>2.0</td><td>ND</td></tr><tr><td>17</td><td>&gt;100 [&gt;369]</td><td>ND</td><td>64 [236]</td><td>&lt;0.64</td><td>ND</td></tr><tr><td>18</td><td>&gt;100 [&gt;317]</td><td>ND</td><td>56 [178]</td><td>&lt;0.56</td><td>ND</td></tr><tr><td>19</td><td>&gt;100 [&gt;332]</td><td>ND</td><td>50 [166]</td><td>&lt;0.50</td><td>ND</td></tr><tr><td>20</td><td>100 [334]</td><td>ND</td><td>190 [602]</td><td>1.9</td><td>237</td></tr><tr><td>21</td><td>&gt;100 [&gt;299]</td><td>ND</td><td>47 [141]</td><td>&lt;0.47</td><td>ND</td></tr><tr><td>22</td><td>&gt;100 [&gt;448]</td><td>ND</td><td>178 [797]</td><td>&lt;1.8</td><td>ND</td></tr><tr><td>23</td><td>&gt;100 [&gt;404]</td><td>&gt;100 [&gt;404]</td><td>45 [182]</td><td>&lt;0.45</td><td>ND</td></tr><tr><td>24</td><td>80 [275]</td><td>60 [206]</td><td>1.6 [5.5]</td><td>0.02</td><td>186</td></tr><tr><td>25</td><td>&gt;100 [&gt;319]</td><td>ND</td><td>181 [578]</td><td>&lt;1.8</td><td>ND</td></tr><tr><td>26</td><td>&gt;100 [&gt;291]</td><td>ND</td><td>183 [533]</td><td>&lt;1.8</td><td>ND</td></tr><tr><td>27</td><td>100 [353]</td><td>ND</td><td>150 [529]</td><td>1.5</td><td>&gt;1000</td></tr><tr><td>28</td><td>20 [55]</td><td>ND</td><td>47 [130]</td><td>2.3</td><td>&lt;111</td></tr><tr><td>29</td><td>&gt;100 [&gt;351]</td><td>ND</td><td>75 [263]</td><td>&lt;0.75</td><td>471</td></tr><tr><td>30</td><td>&gt;100 [&gt;332]</td><td>ND</td><td>89 [295]</td><td>&lt;0.89</td><td>ND</td></tr><tr><td>31</td><td>&gt;100 [&gt;317]</td><td>ND</td><td>137 [434]</td><td>&lt;1.4</td><td>ND</td></tr><tr><td>32</td><td>&gt;100 [&gt;317]</td><td>ND</td><td>181 [574]</td><td>&lt;1.8</td><td>ND</td></tr><tr><td>33</td><td>&gt;100 [&gt;332]</td><td>ND</td><td>5.5 [18]</td><td>&lt;0.055</td><td>148</td></tr><tr><td>34</td><td>&gt;100 [&gt;371]</td><td>ND</td><td>181 [672]</td><td>&lt;1.8</td><td>&gt;1000</td></tr><tr><td>35</td><td>60 [172]</td><td>ND</td><td>121 [348]</td><td>2.0</td><td>&lt;111</td></tr><tr><td>36</td><td>40 [121]</td><td>60 [181]</td><td>41 [124]</td><td>1.0</td><td>ND</td></tr><tr><td>37</td><td>20 [53]</td><td>40 [106]</td><td>30 [80]</td><td>1.5</td><td>165</td></tr><tr><td>38</td><td>50 [118]</td><td>30 [71]</td><td>28 [66]</td><td>0.56</td><td>&lt;111</td></tr><tr><td>39</td><td>40 [97]</td><td>40 [97]</td><td>73 [178]</td><td>1.8</td><td>ND</td></tr><tr><td>40</td><td>&gt;50 [&gt;168]</td><td>&gt;100 [&gt;336]</td><td>220 [740]</td><td>&lt;4.4</td><td>300</td></tr><tr><td>Isoniazid</td><td>0.1 [0.73]</td><td>0.1 [0.73]</td><td>3000<sup>a</sup></td><td>30 000</td><td>&gt;1000</td></tr><tr><td>Rifampicin</td><td>0.05 [0.061]</td><td>0.05 [0.061]</td><td>700<sup>a</sup></td><td>14 000</td><td>ND</td></tr></table>
e4923a7611c8840b80a69b05cc4ca7fb4e3b970e938df61fb01c68157bd5aedb.png
simple
<table><tr><td></td><td><i>Cedrela</i></td><td><i>Cordia</i></td><td><i>Swietenia</i></td><td><i>Tabebuia</i></td></tr><tr><td><i>Cedrela</i></td><td>0</td><td>0.1759</td><td><i>0.0274</i></td><td><i>0.0394</i></td></tr><tr><td><i>Cordia</i></td><td>0.0863</td><td>0</td><td><i>0.0066</i></td><td>0.0905</td></tr><tr><td><i>Swietenia</i></td><td>0.8157</td><td>0.0891</td><td>0</td><td>0.5315</td></tr><tr><td><i>Tabeuia</i></td><td>0.0834</td><td><i>0.0023</i></td><td>0.4700</td><td>0</td></tr></table>
10c86e057ac04a510363ffa48cf3e5852fc205557f28a1aac591469305da8235.png
complex
<table><tr><td colspan="2">Patients presenting to a hospital with hip fracture (<i>N</i> = 78)</td><td>Admitted, <i>n</i> (%)</td><td>Not admitted, <i>n</i> (%)</td></tr><tr><td rowspan="6">Age (in years)</td><td>50&#8211;59</td><td>7 (26)</td><td>15 (29)</td></tr><tr><td>60&#8211;69</td><td>6 (22)</td><td>12 (23)</td></tr><tr><td>70&#8211;79</td><td>9 (33)</td><td>10 (20)</td></tr><tr><td>80&#8211;89</td><td>4 (15)</td><td>11 (22)</td></tr><tr><td>90 and above</td><td>1 (4)</td><td>3 (6)</td></tr><tr><td><i>t</i> test</td><td colspan="2">&#8722;1.993 (<i>p</i> = 0.040)</td></tr><tr><td rowspan="3">Gender</td><td>Male</td><td>14 (52)</td><td>28 (55)</td></tr><tr><td>Female</td><td>13 (48)</td><td>23 (45)</td></tr><tr><td><i>&#967;</i><sup>2</sup></td><td>0.066 (<i>p</i> = 0.797)</td><td></td></tr><tr><td rowspan="4">Type of fracture</td><td>IC</td><td>11 (41)</td><td>19 (37)</td></tr><tr><td>IT</td><td>15 (55)</td><td>29 (57)</td></tr><tr><td>ST</td><td>1 (4)</td><td>3 (6)</td></tr><tr><td><i>&#967;</i><sup>2</sup></td><td colspan="2">0.224 (<i>p</i> = 0.893)</td></tr><tr><td>Total</td><td></td><td>27 (35)</td><td>51 (65)</td></tr></table>
9db21e9ed9508ae36d132e563f540bea0b1857989590e80026c5ff4372937186.png
simple
<table><tr><td></td><td>IBDelphi</td><td>PLINK (all)</td><td>King robust (all)</td><td>PLINK (by pop.)</td><td>King homo (by pop.)</td></tr><tr><td>PLINK (all)</td><td>.947</td><td>1</td><td>.880</td><td>.963</td><td>.962</td></tr><tr><td>King robust (all)</td><td>.739</td><td>.880</td><td>1</td><td>.814</td><td>.831</td></tr><tr><td>PLINK (by pop.)</td><td>.926</td><td>.963</td><td>.814</td><td>1</td><td>.964</td></tr><tr><td>King homo (by pop.)</td><td>.919</td><td>.962</td><td>.831</td><td>.964</td><td>1</td></tr><tr><td>IBDelphi</td><td>1</td><td>.947</td><td>.739</td><td>.926</td><td>.919</td></tr></table>
3e25be20b47496216967a62d0b89bd0c0a015db735e8b79c93ae242858f9cd70.png
simple
<table><tr><td> </td><td>Tested in past 12 m</td><td>Not tested in past 12 m</td><td><i>P*</i></td></tr><tr><td>Overall number of subjects (N = 349**)</td><td>260</td><td>89</td><td> </td></tr><tr><td>Facilitators by code**</td><td> </td><td> </td><td> </td></tr><tr><td>Health concerns for self or others</td><td>65 (15.4)</td><td>12 (12.5)</td><td>0.47</td></tr><tr><td> Perceived risk</td><td>15 (3.6)</td><td>3 (3.1)</td><td>0.83</td></tr><tr><td> Lab characteristic</td><td>15 (3.6)</td><td>3 (3.1)</td><td>0.83</td></tr><tr><td> Access to transportation</td><td>36 (8.6)</td><td>11 (11.5)</td><td>0.37</td></tr><tr><td> Mobile testing center/SEP</td><td>75 (17.8)</td><td>13 (13.5)</td><td>0.31</td></tr><tr><td> Adequate time</td><td>9 (2.1)</td><td>4 (4.2)</td><td>0.25</td></tr><tr><td> Knowledge of testing</td><td>25 (6.7)</td><td>9 (9.4)</td><td>0.22</td></tr><tr><td> Free testing</td><td>85 (20.2)</td><td>13 (13.5)</td><td>0.13</td></tr><tr><td> Access to MD/PCP</td><td>28 (6.7)</td><td>5 (5.2)</td><td>0.60</td></tr><tr><td> Not having to take initiative</td><td>5 (1.2)</td><td>0 (0)</td><td>0.28</td></tr><tr><td> Rapport with provider</td><td>10 (2.4)</td><td>2 (2.1)</td><td>0.86</td></tr><tr><td> Confidentiality</td><td>8 (1.9)</td><td>1 (1.0)</td><td>0.56</td></tr><tr><td> Motivation</td><td>5 (1.2)</td><td>1 (1.0)</td><td>0.90</td></tr><tr><td> Other</td><td>16 (3.8)</td><td>8 (8.3)</td><td>0.06</td></tr><tr><td> Nothing</td><td>24 (5.7)</td><td>11 (11.5)</td><td>0.04</td></tr></table>
70a63331c82ea2f4c828b4bad56a907f86de81aefa87064a7b34492cf4c5ffe8.png
complex
<table><tr><td>Identification</td><td>Description of the gene</td><td>Primers</td><td>Primer efficiency</td></tr><tr><td rowspan="2">A-E4</td><td rowspan="2">Mitogen-activated protein kinase</td><td>F: 5&#8242;- GAAGATGAGAAACCACAAGCG</td><td rowspan="2">90 %</td></tr><tr><td>R: 5&#8242;- CATTCTGAGGAACTTGGAGAGG</td></tr><tr><td rowspan="2">C-G1</td><td rowspan="2">Importin subunit alpha1a</td><td>F: 5&#8242;- GAACTCATTTTGTGCCCCATC</td><td rowspan="2">92 %</td></tr><tr><td>R: 5&#8242;- GCTGAGGGATTGGAAAAGATTG</td></tr><tr><td rowspan="2">E188</td><td rowspan="2">Intracellular Ras-group-related LRR protein 9</td><td>F: 5&#8242;- GAGAGGCAGGATTGGAGATTG</td><td rowspan="2">94 %</td></tr><tr><td>R: 5&#8242;- TCCGCATCCTTCAACATCTTC</td></tr><tr><td rowspan="2">E-E3</td><td rowspan="2">Polyadenylate-binding protein RBP47</td><td>F: 5&#8242;- TCCTAATGAGCCTAACAAACCTG</td><td rowspan="2">92 %</td></tr><tr><td>R: 5&#8242;- TCCGTCTTATTGCCTTCCAC</td></tr><tr><td rowspan="2">VHA-A1</td><td rowspan="2">V-ATPase catalytic subunit A1</td><td>F: 5&#8217;- CGAGAAGGAAAGCGAGTATGG</td><td rowspan="2">107 %</td></tr><tr><td>R: 5&#8217;- TCATTCACCATCAGACCAGC</td></tr><tr><td rowspan="2">B-D5</td><td rowspan="2">Vacuolar H + -ATPase V0 sector</td><td>F: 5&#8242;- GCAGTCATTATCAGTACCGGG</td><td rowspan="2">89 %</td></tr><tr><td>R: 5&#8242;-TCTAACACCAGCATCACCAAC</td></tr><tr><td rowspan="2">B-E2</td><td rowspan="2">Pectin acetylesterase</td><td>F: 5&#8217;-CACACCCACAAAGAGAAACAG</td><td rowspan="2">103 %</td></tr><tr><td>R: 5&#8217;-TTCCAAGAATGCCCCTTCAG</td></tr><tr><td rowspan="2">12.</td><td rowspan="2">XTH</td><td>F: 5&#8217;-AGAGGTGGGCTTGAGAAAAC</td><td rowspan="2">93 %</td></tr><tr><td>R: 5&#8217;-GAACCCAACGAAGTCTCCTATAC</td></tr><tr><td rowspan="2">B-D9</td><td rowspan="2">26S proteasome</td><td>F: 5&#8217;-TCTTGTCCTCTTTCTGTTCCTTATC</td><td rowspan="2">95 %</td></tr><tr><td>R: 5&#8217;-AATCCTTGCCTCACTTCCAG</td></tr><tr><td rowspan="2">C-A3</td><td rowspan="2">Histone H2B</td><td>F: 5&#8242;- TTGGTAACAGCCTTAGTTCCTC</td><td rowspan="2">89 %</td></tr><tr><td>R: 5&#8242;- AAAGCCTACCATCACTTCTCG</td></tr><tr><td rowspan="2">PP2ACS</td><td rowspan="2">PROTEIN PHOSPHATASE 2A catalytic subunit</td><td>F: 5&#8217;- CGATGTGTGATCTCCTATGGTC</td><td rowspan="2">98 %</td></tr><tr><td>R: 5&#8217;- AAGCTGATGGGCTCTAGAAATC</td></tr></table>
5e8a3d34e6ffb02b2fc8ae77e6bdfa6707b1512dc3e1c12a848cd071382ae087.png
complex
<table><tr><td></td><td colspan="4">Anti-Ro antibody</td></tr><tr><td></td><td>B</td><td>SE*</td><td>95% CI</td><td><i>P</i>-value</td></tr><tr><td>Constant</td><td>1.709</td><td>0.236</td><td>1.218 to 2.200</td><td>0.000</td></tr><tr><td>IL-21 (pg/ml)</td><td>0.001</td><td>0.000</td><td>0.000 to 0.001</td><td>0.014</td></tr><tr><td>IgG1 (ug/ml)</td><td>0.013</td><td>0.004</td><td>0.004 to 0.022</td><td>0.008</td></tr></table>
b7de122ab4e2b5e9449a1f7610d4fca13fdaf10d663691f3d77edd8c524fa695.png
simple
<table><tr><td>SCG Feature Point</td><td><i>AS</i></td><td><i>MC</i></td><td><i>IM</i></td><td><i>AO</i></td><td><i>IC</i></td><td><i>RE</i></td><td><i>AC</i></td><td><i>MO</i></td><td><i>RF</i></td></tr><tr><td>mean</td><td>1.04</td><td>1.41</td><td>1.78</td><td>0.37</td><td>1.49</td><td>1.22</td><td>1.30</td><td>1.34</td><td>1.10</td></tr><tr><td>&#177; SD</td><td>0.7</td><td>0.5</td><td>0.8</td><td>0.7</td><td>0.6</td><td>0.8</td><td>0.4</td><td>0.7</td><td>0.6</td></tr></table>
c6d1e15932ba54793897f692760789f1319af689a0034cb0b9f8b293f3d8b911.png
simple
<table><tr><td>Time (d)</td><td>Number of identified proteins<sup>a</sup></td><td>Number of secreted proteins<sup>b</sup> (percentage of identified proteins)</td></tr><tr><td>0</td><td>89</td><td>31 (35 %)</td></tr><tr><td>7</td><td>1009</td><td>150 (15 %)</td></tr><tr><td>14</td><td>1077</td><td>163 (15 %)</td></tr><tr><td>21</td><td>1149</td><td>170 (15 %)</td></tr><tr><td>28</td><td>1151</td><td>170 (15 %)</td></tr><tr><td>42</td><td>1035</td><td>157 (15 %)</td></tr></table>
70190849accccde69af192405d63ef803ff60b0d79f07e94282a898ba7e45a68.png
simple
<table><tr><td></td><td>Tested <i>N</i> = 3810</td><td>Untested <i>N</i> = 904</td><td><i>p</i>-value</td></tr><tr><td></td><td>n (%)</td><td>n (%)</td><td></td></tr><tr><td>Patient characteristics</td><td></td><td></td><td></td></tr><tr><td>Age</td><td>(<i>n</i> = 3810)</td><td>(<i>n</i> = 904)</td><td></td></tr><tr><td>&lt; 1 years</td><td>1756(46.1)</td><td>418(46.2)</td><td>0.94</td></tr><tr><td> 1- &lt; 5 years</td><td>2054(53.9)</td><td>486(53.8)</td><td></td></tr><tr><td> Mean age (years)<sup>a</sup></td><td>1.4(1.1)</td><td>1.4(1.1)</td><td>0.99</td></tr><tr><td>Gender</td><td>(<i>n</i> = 3810)</td><td>(<i>n</i> = 904)</td><td></td></tr><tr><td> Male</td><td>2056(54.0)</td><td>524(58.0)</td><td>0.03</td></tr><tr><td>Illness Severity</td><td></td><td></td><td></td></tr><tr><td>Death</td><td>(<i>n</i> = 3810)</td><td>(<i>n</i> = 904)</td><td></td></tr><tr><td> Discharged dead</td><td>103(2.7)</td><td>177(19.6)</td><td>&lt;0.01</td></tr><tr><td>Oxygen saturation</td><td>(<i>n</i> = 3796)</td><td>(<i>n</i> = 900)</td><td></td></tr><tr><td>&lt; 90 %</td><td>628(16.5)</td><td>157(17.4)</td><td>0.52</td></tr><tr><td> Mean Oxygen saturation<sup>a</sup></td><td>93.7(6.8)</td><td>93.4(7.6)</td><td>0.26</td></tr></table>
a865614ac434c2bfcd7fdddde720a44c0a92b8fd5c93eae8ad8dd9e3e68ccef8.png
simple
<table><tr><td>miRNA name</td><td>Log Fc</td><td>Log CPM</td><td>p value</td><td>FDR</td></tr><tr><td>hsa-miR-96</td><td>5.89073</td><td>2.930204</td><td>0.000245</td><td>0.000186</td></tr><tr><td>hsa-miR-1224</td><td>5.217967</td><td>3.015217</td><td>0.000519</td><td>0.000361</td></tr><tr><td>hsa-miR-1293</td><td>3.171918</td><td>14.19242</td><td>0.00203</td><td>0.001093</td></tr><tr><td>hsa-miR-4467</td><td>3.174797</td><td>12.62878</td><td>0.00204</td><td>0.001093</td></tr><tr><td>hsa-miR-6848</td><td>4.143784</td><td>3.760948</td><td>0.00578</td><td>0.002233</td></tr><tr><td>hsa-miR-6849</td><td>3.118348</td><td>7.30397</td><td>0.00826</td><td>0.003</td></tr><tr><td>hsa-miR-4488</td><td>3.184877</td><td>5.073045</td><td>0.000404</td><td>0.010436</td></tr><tr><td>hsa-miR-425</td><td>3.481839</td><td>4.249725</td><td>0.000572</td><td>0.012611</td></tr><tr><td>hsa-miR-4732</td><td>2.578799</td><td>8.273334</td><td>0.000616</td><td>0.013178</td></tr><tr><td>hsa-miR-484</td><td>2.389806</td><td>7.714758</td><td>0.001566</td><td>0.028757</td></tr><tr><td>hsa-miR-5094</td><td>5.125813</td><td>1.680093</td><td>0.002864</td><td>0.04123</td></tr></table>
ea470a460e3abf032c09fb9c68081692f1d39984bf18774f790af0fdeb638494.png
complex
<table><tr><td>County</td><td> </td><td colspan="4">Yunlin (industrialized county)</td><td colspan="3">Yilan (reference county)</td></tr><tr><td>Area (km<sup>2</sup>)<sup>a</sup></td><td colspan="4">1290.835</td><td colspan="4">2143.625</td></tr><tr><td>Year</td><td>1996&#8211;1998</td><td>1999&#8211;2002</td><td>2002&#8211;2004</td><td>2005&#8211;2007</td><td>1996&#8211;1998</td><td>1999&#8211;2002</td><td>2002&#8211;2004</td><td>2005&#8211;2007</td></tr><tr><td>Population (person)<sup>a</sup></td><td>752,427</td><td>746,241</td><td>742,797</td><td>725,672</td><td>465,120</td><td>465,004</td><td>464,107</td><td>460,398</td></tr><tr><td>Number of large manufacturing<sup>b</sup></td><td>35</td><td>42</td><td>48</td><td>42</td><td>22</td><td>21</td><td>25</td><td>22</td></tr><tr><td>Agricultural land (Hectare)<sup>c</sup></td><td>112,870</td><td>112,364</td><td>111,992</td><td>112,550</td><td>58,265</td><td>158,641</td><td>164,438</td><td>200,826</td></tr><tr><td>Number of doctors (/1000 people)<sup>a</sup></td><td>0.66</td><td>0.71</td><td>0.76</td><td>0.92</td><td>0.86</td><td>1.00</td><td>1.12</td><td>1.19</td></tr><tr><td>Number of hospital (/1000 people)<sup>a</sup></td><td>0.031</td><td>0.032</td><td>0.029</td><td>0.026</td><td>0.030</td><td>0.032</td><td>0.026</td><td>0.026</td></tr><tr><td>Life expectancy at birth</td><td>74.05</td><td>74.88</td><td>75.51</td><td>76.16</td><td>74.84</td><td>75.8</td><td>76.88</td><td>77.65</td></tr><tr><td>Life expectancy at 5 years old</td><td>69.74</td><td>70.52</td><td>71.12</td><td>71.69</td><td>70.62</td><td>71.51</td><td>72.59</td><td>73.31</td></tr><tr><td>Life expectancy at 65 years old</td><td>15.98</td><td>16.63</td><td>17.17</td><td>17.78</td><td>16.59</td><td>17.05</td><td>17.94</td><td>18.64</td></tr><tr><td>Mortality rate (/10000)</td><td>671.41</td><td>611.04</td><td>681.14</td><td>751.94</td><td>698.77</td><td>684.57</td><td>695.4</td><td>744.42</td></tr></table>
9b910b66fecddeee38e58cf00a7f279de3b61447ea0dfc1149d56509e9fac546.png
complex
<table><tr><td></td><td><i>N</i> (%)</td></tr><tr><td colspan="2">Surgical resection</td></tr><tr><td> Yes/no</td><td>13 (25)/40 (75)</td></tr><tr><td> Margin: R0/R1</td><td>10 (19)/3 (6)</td></tr><tr><td colspan="2">Type of surgery</td></tr><tr><td> Liver resection</td><td>3 (6)</td></tr><tr><td> CRS and HIPEC</td><td>5 (9)</td></tr><tr><td> Primary tumor resection and liver resection</td><td>3 (6)</td></tr><tr><td> Primary + CRS and HIPEC1</td><td>1 (28)</td></tr><tr><td> Lung resection</td><td>1 (2)</td></tr></table>
e7633c1ea5c1a4ad9c82f37c8bb7469ecd23520a2c07392c68481361a7dd24dc.png
simple
<table><tr><td>Authors</td><td>Population</td><td>Outcome parameters</td><td>Validity</td><td>Quality</td><td>Quantity</td><td>Activity</td></tr><tr><td>Dobkin et al. [33]</td><td>Stroke</td><td>Walking speed, bouts of walking, gait symmetry</td><td>Leave-one-subject-out method</td><td>-</td><td>x</td><td>Walking</td></tr><tr><td>Zampieri et al. [44]</td><td>PD</td><td>Stride length, stride velocity, cadence, peak arm swing velocity on the MAS, and turning velocity</td><td>Leave-one-subject-out method</td><td>-</td><td>x</td><td>Sitting, standing, walking, turning</td></tr><tr><td>Mizuike et al. [37]</td><td>Stroke</td><td>Accelerometers derivatives, raw RMS, normalized RMS, autocorrelation function</td><td>Cross-validation</td><td>x</td><td>x</td><td>Walking</td></tr><tr><td>Prajapati et al. [40]</td><td>Stroke</td><td>Walking bouts, total walking time, gait speed, number of steps, gait symmetry, swing symmetry, cadence</td><td>Cross-validation</td><td>x</td><td>-</td><td>Walking</td></tr></table>
eaffcb29739f04991a80b08b1ee7f8d2bbbe5aba5ebc179fe10d8ced52b9dd43.png
simple
<table><tr><td>Statement</td><td>N</td><td>Mean [Range]</td></tr><tr><td>Feel supported in carrying out my work at the clinic</td><td>20</td><td>4.05 [2-5]</td></tr><tr><td>Feel confident when carrying out my work at the clinic</td><td>20</td><td>4.65 [4-5]</td></tr><tr><td>Feel the work I do is important and well valued</td><td>20</td><td>4.55 [2-5]</td></tr><tr><td>Find the work load at the clinic is too demanding</td><td>20</td><td>3.3 [2-5]</td></tr><tr><td>The facilities at the KCC clinic are adequate for me to carry out my work</td><td>20</td><td>2.65 [1-5]</td></tr><tr><td>Work at KCC is stressful</td><td>20</td><td>2.3 [1-5]</td></tr><tr><td>Training that I have undertaken has improved my skills</td><td>20</td><td>4.7 [4-5]</td></tr><tr><td>Training has improved the knowledge</td><td>20</td><td>4.4 [4-5]</td></tr><tr><td>Quality of care I provide has improved</td><td>20</td><td>4.6 [4-5]</td></tr><tr><td>Each patient is given the right amount of time</td><td>20</td><td>3.45 [2-5]</td></tr></table>
8efd772a12da89f33543372286ebfbb01adec4a5d0ef6c183ded65c3698fd08f.png
simple
<table><tr><td>Cut-Off</td><td>Sensitivity</td><td>1-Specificity</td></tr><tr><td>0</td><td>1.000</td><td>1.000</td></tr><tr><td>1</td><td>1.000</td><td>0.944</td></tr><tr><td>2</td><td>1.000</td><td>0.901</td></tr><tr><td>3</td><td>1.000</td><td>0.789</td></tr><tr><td>4</td><td>1.000</td><td>0.606</td></tr><tr><td>5</td><td>0.927</td><td>0.408</td></tr><tr><td>6</td><td>0.805</td><td>0.296</td></tr><tr><td>7<sup>a</sup></td><td>0.683</td><td>0.141</td></tr><tr><td>8</td><td>0.390</td><td>0.042</td></tr><tr><td>9</td><td>0.122</td><td>0.000</td></tr><tr><td>10</td><td>0.000</td><td>0.000</td></tr></table>
c2ccb7e33769256e49a3620a40b51e8a935edf90211425b9c3b4cf58d005f54b.png
complex
<table><tr><td>Effect Size</td><td colspan="2">CV Method</td><td colspan="2">WRS Method</td></tr><tr><td></td><td>FP mean(STD)</td><td>TP mean(STD)</td><td>FP mean(STD)</td><td>TP mean(STD)</td></tr><tr><td>0.1</td><td>1.0(1.0)</td><td>4.1(4.15)</td><td>0.65(0.85)</td><td>0.25(0.54)</td></tr><tr><td>0.2</td><td>0.6(0.73)</td><td>37.4(14.47)</td><td>0.75(0.83)</td><td>0.1(0.3)</td></tr><tr><td>0.3</td><td>1.1(1.04)</td><td>85.45(11.1)</td><td>0.9(1.09)</td><td>0.1(0.3)</td></tr><tr><td>0.4</td><td>0.9(0.77)</td><td>97.95(3.25)</td><td>0.85(0.91)</td><td>0.05(0.22)</td></tr></table>
e3dc5b50e02efab9932db4c85e1da0c2aff936f49ae9e6eda8f3bf3f64b999a4.png
complex
<table><tr><td>Disease</td><td>Gene</td><td>Inheritance mode</td><td>Other clinical features (main)</td></tr><tr><td colspan="4">Monogenic diseases causing small artery occlusion (lacunar) ischemic stroke</td></tr><tr><td> CADASIL [78]</td><td><i>NOTCH3</i></td><td>autosomal dominant</td><td>migraine with aura, mood disturbance, progressive cognitive impairment</td></tr><tr><td> CARASIL [79, 80]</td><td><i>HTRA1</i></td><td>autosomal recessive</td><td>alopecia, dementia, gait disturbance, low back pain, mood disturbance</td></tr><tr><td> RVCL [81&#8211;84]</td><td><i>TREX1</i></td><td>autosomal dominant</td><td>visual loss, stroke, dementia, seizures, headache, personality disorders</td></tr><tr><td colspan="4">Monogenic diseases causing large artery and small artery occlusion (lacunar) ischemic stroke</td></tr><tr><td> Sickle cell disease [85, 86]</td><td><i>HBB</i></td><td>autosomal recessive</td><td>more seldom hemorrhagic stroke, vaso-occlusive or painful crisis, retinopathy, chronic leg ulcers, increased susceptibility to infection, anemia</td></tr><tr><td> Homocystinuria [87, 88]</td><td><i>CBS*</i></td><td>autosomal recessive*</td><td>thromboembolism, mental retardation, ectopia lentis, skeletal abnormalities</td></tr><tr><td> Fabry disease [89&#8211;91]</td><td><i>GLA</i></td><td>X-linked</td><td>acroparesthesia, hypohidrosis, angiokeratoma, chronic kidney disease, cardiomyopathy</td></tr><tr><td> PXE [92&#8211;94]</td><td><i>ABCC6</i></td><td>autosomal recessive</td><td>peau d&#8217;orange lesions, ocular complications, hypertension, peripheral artery disease, coronary artery disease, gastrointestinal bleeding</td></tr><tr><td colspan="4">Monogenic diseases causing ischemic stroke of other etiologies</td></tr><tr><td> Vascular EDS [95&#8211;98]</td><td><i>COL3A1</i></td><td>autosomal dominant</td><td>dissection and rupture of arteries, rupture or hollow organs, easy bruising, thin skin with visible veins</td></tr><tr><td> Marfan syndrome [99&#8211;102]</td><td><i>FBN1*</i></td><td>autosomal dominant</td><td>aortic root dilatation and dissection, ectopia lentis, marfanoid habitus, dural ectasia, pneumothorax</td></tr><tr><td colspan="4">Monogenic mitochondrial disorders</td></tr><tr><td> MELAS [103&#8211;105]</td><td><i>tRNA Leu</i></td><td>maternal inheritance</td><td>seizures, recurrent headaches, anorexia, recurrent vomiting, myopathy with exercise intolerance</td></tr><tr><td colspan="4">Monogenic diseases causing intracerebral hemorrhage</td></tr><tr><td> CAA [106&#8211;110]</td><td><i>APP, CST3</i></td><td>autosomal dominant</td><td>dementia, transient neurological symptoms and seizures</td></tr><tr><td> COL4A1 syndrome [111&#8211;115]</td><td><i>COL4A1</i></td><td>autosomal dominant</td><td>more seldom lacunar ischemic stroke, porencephaly, intracranial aneurysms, retinal arteriolar tortuosities and haemorrhage, cataract, Axenfeld-Rieger syndrome, hematuria, renal cysts, mild renal failure, muscle cramps</td></tr></table>
8d8e9446c1cc56a2b514498bd0ae71de281c6849ac1afe002aa8b093faecee10.png
simple
<table><tr><td>Group; cases</td><td>Dc, mm</td><td>Dc, mean &#177;SD, mm</td><td>Age, mean &#177; SD, y</td><td>Body mass index, mean &#177; SD, kg/m<sup>2</sup></td><td>Rate of expansion, mean &#177; SD</td></tr><tr><td>1; N = 16</td><td>Dc = 0</td><td>0.0 &#177; 0.0</td><td>45.6 &#177; 9.8</td><td>19.5 &#177; 1.8</td><td>1.3 &#177; 0.1</td></tr><tr><td>2; N = 24</td><td>0 &lt; Dc &lt; 10</td><td>4.0 &#177; 2.2</td><td>47.3 &#177; 10.3</td><td>21.9 &#177; 2.5</td><td>1.4 &#177; 0.2</td></tr><tr><td>3; N = 10</td><td>10 &#8804; Dc</td><td>13.2 &#177; 3.7</td><td>53.6 &#177; 10.4</td><td>22.7 &#177; 1.8</td><td>1.5 &#177; 0.2</td></tr></table>
409c139ba3d790448e3b5cd7eb019ea667fbd42cd24665623806fc64d4734d6d.png
complex
<table><tr><td colspan="2"><i>Mangifera indica</i> L.<i>Nutrition value per 100 g</i></td></tr><tr><td>Energy</td><td>60 Kcal</td></tr><tr><td>Fruit composition</td><td>Quantity</td></tr><tr><td>Carbohydrates</td><td>14.98 g</td></tr><tr><td>Protein</td><td>0.82 g</td></tr><tr><td>Fat</td><td>0.38 g</td></tr><tr><td>Fiber</td><td>1.6 g</td></tr><tr><td colspan="2">Vitamins</td></tr><tr><td>Vitamin C</td><td>36.4 mg</td></tr><tr><td>Vitamin E</td><td>1.12 mg</td></tr><tr><td>Vitamin A</td><td>1082 IU</td></tr><tr><td>Niacin (vit B3)</td><td>669 &#956;g</td></tr><tr><td>Pantothenic acid (vit B5)</td><td>160 &#956;g</td></tr><tr><td>Pyridoxine (vit B6)</td><td>119 &#956;g</td></tr><tr><td>Riboflavin (vit B2)</td><td>38 &#956;g</td></tr><tr><td>Thiamin (vit B1)</td><td>28 &#956;g</td></tr><tr><td>Folates</td><td>43 &#956;g</td></tr><tr><td>Vitamin K</td><td>4.2 &#956;g</td></tr><tr><td colspan="2">Minerals</td></tr><tr><td>Potassium</td><td>168 mg</td></tr><tr><td>Phosphorus</td><td>14 mg</td></tr><tr><td>Calcium</td><td>11 mg</td></tr><tr><td>Magnesium</td><td>10 mg</td></tr><tr><td>Sodium</td><td>1 mg</td></tr><tr><td>Copper</td><td>110 &#956;g</td></tr><tr><td>Iron</td><td>160 &#956;g</td></tr><tr><td>Manganese</td><td>27 &#956;g</td></tr><tr><td>Zinc</td><td>90 &#956;g</td></tr><tr><td colspan="2">Carotenoids</td></tr><tr><td>&#946;&#8722;Carotene</td><td>445 &#956;g</td></tr><tr><td>&#945;&#8722;Carotene</td><td>17 &#956;g</td></tr></table>
11a44d3f0f547d9f0a447d7bbc848770881cbd13c1ce85f7967fec3a03b7aae4.png
simple
<table><tr><td>Cultivar (<i>cv.</i>)</td><td>Number of samples</td><td>Geographical origin</td></tr><tr><td>Coratina</td><td>10</td><td>Bari (Apulia, Italy)</td></tr><tr><td>Ogliarola Garganica</td><td>10</td><td>Gargano, Foggia (Apulia, Italy)</td></tr><tr><td>Ogliarola Barese</td><td>10</td><td>Bari (Apulia, Italy)</td></tr><tr><td>Cima di Mola</td><td>10</td><td>Bari (Apulia, Italy)</td></tr><tr><td>Picholine</td><td>10</td><td>Bari (Apulia, Italy)</td></tr><tr><td>Peranzana</td><td>3</td><td>San Severo, Foggia (Apulia, Italy)</td></tr><tr><td>Carolea</td><td>8</td><td>Calabria</td></tr><tr><td>Rossanese</td><td>3</td><td>Calabria</td></tr><tr><td>Picual</td><td>3</td><td>Spain</td></tr><tr><td>Kalamata</td><td>3</td><td>Greece</td></tr><tr><td>Koroneiki</td><td>3</td><td>Greece</td></tr></table>
a142b051603fe34559b8c9a72a079afee84af5b8e332f1b360fddd4809fef666.png
complex
<table><tr><td>Workflow A</td><td>Workflow B</td><td>Workflow C</td></tr><tr><td>+ ease of application</td><td>+ very straightforward, no parameters or thresholds</td><td>+ can integrate many existing programs</td></tr><tr><td>+ software is available</td><td>+ guaranteed result in several rounds</td><td>+ different algorithms address particular properties of promoters</td></tr><tr><td>+ the spectrum of existing methods covers all particular aspects of transcriptional regulation</td><td> </td><td>+ optimization of a collection of combinatorial modules instead of optimization of each module separately</td></tr><tr><td>&#8211; big number of methods to choose from (over 150 can be found in the Internet)</td><td>&#8211; may lead to a scission of a functional module rendering all parts non functional</td><td rowspan="4">&#8211; huge number of predicted features require much memory and CPU = &gt; specificity filtering should be applied before modules optimization</td></tr><tr><td>&#8211; relative performance of methods differs for different datasets</td><td>&#8211; high lab work and time investments</td></tr><tr><td>&#8211; chance of a correct prediction is ~5-10% [5]</td><td> </td></tr><tr><td>&#8211; impossible to estimate the number of required rounds</td><td> </td></tr></table>
0b93595ed66acfcc367a6c88cbfb111203ddd7b7b8a405c9f66932f1ae43f728.png
complex
<table><tr><td rowspan="2">First author</td><td rowspan="2">Year</td><td rowspan="2">Ethnicity</td><td rowspan="2">Disease</td><td rowspan="2">Sample</td><td colspan="3">Number</td><td rowspan="2">Gender (M/F)</td><td rowspan="2">Age (years)</td><td rowspan="2">Method</td><td rowspan="2">NOS score</td></tr><tr><td>Tumor</td><td>Benign</td><td>Normal</td></tr><tr><td>Longo [29]</td><td>2014</td><td>Caucasians</td><td>HNSCC</td><td>Tissue</td><td>96</td><td>0</td><td>79</td><td>75/21</td><td>59 (20~90)</td><td>qMSP</td><td>8</td></tr><tr><td>Liu [28]</td><td>2013</td><td>Asians</td><td>CC</td><td>Tissue</td><td>40</td><td>0</td><td>40</td><td>0/40</td><td>&#8212;</td><td>MSP</td><td>6</td></tr><tr><td>Weiss [10]</td><td>2011</td><td>Caucasians</td><td>HNSCC</td><td>Tissue</td><td>49</td><td>0</td><td>31</td><td>&#8212;</td><td>63.7 &#177; 11.8</td><td>MSP</td><td>7</td></tr><tr><td>Yang [9]</td><td>2010</td><td>Caucasians</td><td>CC</td><td>Tissue</td><td>60</td><td>40</td><td>20</td><td>&#8212;</td><td>46 (38~57) </td><td>qMSP</td><td>7</td></tr><tr><td>Yanatatsaneejit [20]</td><td>2008</td><td>Asians</td><td>NPC</td><td>Tissue</td><td>46</td><td>0</td><td>20</td><td>&#8212;</td><td>&#8212;</td><td>Duplex MSP</td><td>6</td></tr><tr><td rowspan="2">Brait [5]</td><td rowspan="2">2008</td><td rowspan="2">Caucasians</td><td rowspan="2">BCa</td><td rowspan="2">Tissue</td><td>93</td><td>0</td><td>26</td><td>&#8212;</td><td>67 (39~83)</td><td>qMSP</td><td rowspan="2">8</td></tr><tr><td>25</td><td>0</td><td>5</td><td>&#8212;</td><td>66 (34~84)</td><td>qMSP</td></tr><tr><td>Yu [21]</td><td>2003</td><td>Asians</td><td>BCa</td><td>Tissue</td><td>132</td><td>23</td><td>0</td><td>107/25</td><td>&#8212;</td><td>MSP</td><td>8</td></tr><tr><td>Kitkumthorn [19]</td><td>2006</td><td>Asians</td><td>CC</td><td>Tissue</td><td>30</td><td>24</td><td>25</td><td>&#8212;</td><td>&#8212;</td><td>Duplex MSP</td><td>6</td></tr><tr><td>Tokumaru [12]</td><td>2004</td><td>Asians</td><td>HNSCC</td><td>Tissue</td><td>20</td><td>0</td><td>11</td><td>&#8212;</td><td>&#8212;</td><td>MSP</td><td>6</td></tr><tr><td>Yu [21]</td><td>2003</td><td>Asians</td><td>HCC</td><td>Tissue</td><td>28</td><td>0</td><td>28</td><td>&#8212;</td><td>&#8212;</td><td>MSP</td><td>6</td></tr></table>
6727a965b05052dc40c9d4b99dd761f3a50e2243e8ef343c540f6e35e2e9f9c7.png
simple
<table><tr><td></td><td>Migraine in AH-group</td><td>Migraine in Non-AH group</td><td>Total</td></tr><tr><td>Females</td><td>6 (50 %)</td><td>48 (33 %)</td><td>54 (34 %)</td></tr><tr><td>Males</td><td>1 (11 %)</td><td>7 (8 %)</td><td>8 (8 %)</td></tr><tr><td>Total</td><td>7 (33 %)</td><td>55 (24 %)</td><td>62 (24 %)</td></tr></table>
62949ac25147e2cd2d0af3e4b580c6542a2953063884257ccb57e1ffa9dcec2b.png
complex
<table><tr><td rowspan="2">Plants</td><td colspan="4">Colony forming units at 600 mg/ml</td><td colspan="4">Colony forming units at 450 mg/ml</td></tr><tr><td>10 (min)</td><td>20 (min)</td><td>40 (min)</td><td>0 minutes (ctrl)</td><td>10 (min)</td><td>20 (min)</td><td>40 (min)</td><td>0 minutes (ctrl)</td></tr><tr><td><i>S. aculeastrum</i></td><td>5.00 &#177; 1.70<sup>b</sup></td><td>4.00 &#177; 1.70<sup>ab</sup></td><td>4.00 &#177; 1.70<sup>a</sup></td><td>43 &#177; 1.70<sup>c</sup></td><td>5.00 &#177; 1.60<sup>b</sup></td><td>4.00 &#177; 1.60<sup>ab</sup></td><td>4.00 &#177; 1.60<sup>a</sup></td><td>43 &#177; 1.60<sup>c</sup></td></tr><tr><td><i>P. africana</i></td><td>6.00 &#177; 1.70<sup>b</sup></td><td>5.00 &#177; 1.70<sup>ab</sup></td><td>4.00 &#177; 1.70<sup>a</sup></td><td>72 &#177; 1.70<sup>c</sup></td><td>5.00 &#177; 1.60<sup>b</sup></td><td>4.00 &#177; 1.60<sup>ab</sup></td><td>4.00 &#177; 1.60<sup>a</sup></td><td>72 &#177; 1.60<sup>c</sup></td></tr><tr><td><i>S. cordatum</i></td><td>5.00 &#177; 1.70<sup>b</sup></td><td>4.00 &#177; 1.70<sup>ab</sup></td><td>3.00 &#177; 1.70<sup>a</sup></td><td>34 &#177; 1.70<sup>c</sup></td><td>5.00 &#177; 1.60<sup>b</sup></td><td>4.00 &#177; 1.60<sup>ab</sup></td><td>3.00 &#177; 1.60<sup>a</sup></td><td>34 &#177; 1.60<sup>c</sup></td></tr><tr><td><i>L. kituiensis</i></td><td>16.00 &#177; 1.70<sup>b</sup></td><td>12.00 &#177; 1.70<sup>ab</sup></td><td>8.00 &#177; 1.70<sup>a</sup></td><td>44 &#177; 1.70<sup>c</sup></td><td>17.00 &#177; 1.60<sup>b</sup></td><td>14.00 &#177; 1.60<sup>ab</sup></td><td>12.00 &#177; 1.60<sup>a</sup></td><td>44 &#177; 1.60<sup>c</sup></td></tr><tr><td><i>O. lamiifolium</i></td><td>13.00 &#177; 1.70<sup>b</sup></td><td>11.00 &#177; 1.70<sup>ab</sup></td><td>8.00 &#177; 1.70<sup>a</sup></td><td>56 &#177; 1.70<sup>c</sup></td><td>15.00 &#177; 1.60<sup>b</sup></td><td>11.00 &#177; 1.60<sup>ab</sup></td><td>10.00 &#177; 1.60<sup>a</sup></td><td>56 &#177; 1.60<sup>c</sup></td></tr><tr><td><i>S. oleracea</i></td><td>14.00 &#177; 1.70<sup>b</sup></td><td>14.00 &#177; 1.70<sup>ab</sup></td><td>11.00 &#177; 1.70<sup>a</sup></td><td>58 &#177; 1.70<sup>c</sup></td><td>16.00 &#177; 1.60<sup>b</sup></td><td>13.00 &#177; 1.60<sup>ab</sup></td><td>10.00 &#177; 1.60<sup>a</sup></td><td>58 &#177; 1.60<sup>c</sup></td></tr><tr><td>0 extracts (ctrl)</td><td>76.00 &#177; 1.70<sup>a</sup></td><td>76.00 &#177; 1.70<sup>a</sup></td><td>74.00 &#177; 1.70<sup>a</sup></td><td>81.00 &#177; 1.70<sup>a</sup></td><td>76.00 &#177; 1.60<sup>a</sup></td><td>76.00 &#177; 1.60<sup>a</sup></td><td>74.00 &#177; 1.60<sup>a</sup></td><td>81.00 &#177; 1.60<sup>a</sup></td></tr></table>
13447b0f42c98f67764a54ee050a8288a35b91df36b0a249a190fe6359f4ddf0.png
complex
<table><tr><td></td><td colspan="4">30 bp VNTR</td><td></td><td></td><td colspan="2">941 G/T</td></tr><tr><td></td><td colspan="4">Allele</td><td></td><td></td><td colspan="2">Allele</td></tr><tr><td></td><td>2R</td><td>3R</td><td>4R</td><td>5R</td><td>Short (2R, 3R)</td><td>Long (4R, 5R)</td><td>G</td><td>T</td></tr><tr><td>Transmitted</td><td>2</td><td>52</td><td>38</td><td>1</td><td>54</td><td>39</td><td>55</td><td>35</td></tr><tr><td>Non-transmitted</td><td>0</td><td>40</td><td>53</td><td>0</td><td>39</td><td>54</td><td>35</td><td>55</td></tr><tr><td>&#967;<sup>2</sup> (<i>P</i>-value)</td><td></td><td></td><td></td><td></td><td>2.42, 1df (0.120)</td><td></td><td>4.48, 1df (0.034)</td><td></td></tr></table>